General Atlantic and UBS Announce Strategic Partnership Focused on Private Credit Opportunities

General Atlantic and UBS Announce Strategic Partnership Focused on Private Credit Opportunities

NEW YORK & ZURICH–(BUSINESS WIRE)–
General Atlantic and UBS Group AG (NYSE: UBS) announce today a strategic partnership focused on private credit opportunities. The collaboration between UBS and General Atlantic Credit (GA Credit) aims to enhance investing clients’ and borrowers’ access to a broader set of direct lending and other credit products.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250506296938/en/

The partnership formalizes and expands a history of collaboration, bringing together two leading global platforms to create a compelling private credit offering by combining UBS’s advisory and investment banking origination capabilities with General Atlantic’s extensive global network, sourcing reach across industries and geographies, and recognized leadership as a private credit investor.

Bill Ford, Chairman and Chief Executive Officer of General Atlantic, commented: “We are excited to bring together General Atlantic’s deep expertise in private credit investing with UBS’s strengths in origination, global client relationships, and advisory services. Our complementary cultures position us well to scale a market-leading private credit platform, and we look forward to capturing the most compelling opportunities for our investing clients.”

Sergio P. Ermotti, Group Chief Executive Officer of UBS, said: “We’re pleased to enter this strategic partnership with General Atlantic, leveraging our two firms’ individual strengths to jointly deliver a broader range of innovative private credit solutions. This collaboration is rooted in a shared dedication to client centricity, enabling us to bring to bear the best of both our firms’ market leading capabilities across private credit investing, capital markets, and asset management.”

Additional information:

This collaboration advances the GA Credit platform by unlocking differentiated access to proprietary deal flow, delivering customized solutions across the capital structure and business lifecycle, and adding a complementary strategy to Atlantic Park, which will benefit from expanded origination opportunities through the partnership. It also marks a significant step in UBS’s growth ambitions for its Global Banking capital markets platform, enhancing its scale and capabilities.

GA Credit will be responsible for leading the investment activities, leveraging UBS’s origination capabilities, and managing a dedicated private credit team formed through the integration of professionals from both GA Credit and UBS Asset Management’s Credit Investments Group (CIG). Through this collaboration, CIG will have the ability to source incremental private credit assets for its multi-credit strategies.

The strategic partnership will focus on providing senior secured direct lending financing to companies in North America and Western Europe. It will strengthen UBS’s Investment Bank private markets capabilities, particularly in the Americas, by providing private credit solutions across mid- and large-cap structures, including both corporate and sponsor-backed assets in a capital efficient way.

Advisors

Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal counsel to General Atlantic. Latham & Watkins LLP served as legal counsel to UBS.

About UBS

UBS is a leading and truly global wealth manager and the leading universal bank in Switzerland. It also provides diversified asset management solutions and focused investment banking capabilities. UBS manages $6.2 trillion of invested assets as per the first quarter of 2025. UBS helps clients achieve their financial goals through personalized advice, solutions, and products. Headquartered in Zurich, Switzerland, the firm operates in more than 50 markets around the globe. UBS Group shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).

About General Atlantic

General Atlantic is a leading global investor with more than four and a half decades of experience providing capital and strategic support to over 830 companies throughout its history. Established in 1980, General Atlantic continues to be a dedicated partner to visionary founders and investors seeking to build dynamic businesses and create long-term value. The firm leverages its patient capital, operational expertise, and global platform to support a diversified investment platform spanning Growth Equity, Credit, Climate, and Sustainable Infrastructure strategies. General Atlantic manages approximately $108 billion in assets under management, inclusive of all strategies, as of March 31, 2025, with more than 900 professionals in 20 countries across five regions. For more information on General Atlantic, please visit: www.generalatlantic.com.

About General Atlantic Credit

General Atlantic Credit (“GA Credit”) is the dedicated credit investment platform within General Atlantic, a leading global growth investor. GA Credit leverages a demonstrated track record of strategic credit partnerships across market cycles and capital structures alongside General Atlantic’s more than 45 years of domain expertise and company-building capabilities. GA Credit’s Atlantic Park strategy provides flexible capital to high-quality companies seeking a strategic partner at various stages of the corporate and economic lifecycle. This partnership approach enables Atlantic Park to create customized capital solutions tailored to a company’s specific capital needs.

UBS Group AG and UBS AG

Media contact

Switzerland: +41-44-234 85 00

UK: +44-207-567 47 14

Americas: +1-212-882 58 58

APAC: +852-297-1 82 00

www.ubs.com/media

General Atlantic

[email protected]

KEYWORDS: Europe Switzerland United States North America New York

INDUSTRY KEYWORDS: Finance Consulting Business Professional Services Asset Management

MEDIA:

Logo
Logo
Logo
Logo

IQVIA Reports First-Quarter 2025 Results

IQVIA Reports First-Quarter 2025 Results

  • Revenue of $3,829 million
  • GAAP Net Income of $249 million, Adjusted EBITDA of $883 million
  • GAAP Diluted Earnings per Share of $1.40, Adjusted Diluted Earnings per Share of $2.70
  • R&D Solutions quarterly bookings of $2.1 billion, resulting in trailing-twelve-month bookings of $9.7 billion and a trailing-twelve-month book-to-bill ratio of 1.14x
  • R&D Solutions contracted backlog of $31.5 billion, up 4.8 percent year-over-year
  • TAS Revenue of $1,546 million, up 6.4 percent reported year-over-year and 7.6 percent at constant currency
  • Operating Cash Flow of $568 million and Free Cash Flow of $426 million, up 13 percent year-over-year, representing 89 percent of Adjusted Net Income
  • Repurchased $425 million of common stock
  • Raised full-year revenue guidance by $275 million to reflect more favorable foreign currency exchange rates; reaffirmed profit guidance

RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended March 31, 2025.

First-Quarter 2025 Operating Results

Revenue for the first quarter of $3,829 million increased 2.5 percent on a reported basis and 3.5 percent at constant currency, compared to the first quarter of 2024. Technology & Analytics Solutions (TAS) revenue of $1,546 million increased 6.4 percent on a reported basis and 7.6 percent at constant currency. Research & Development Solutions (R&DS) revenue of $2,102 million increased 0.3 percent on a reported basis and 1.1 percent at constant currency. Excluding reimbursed expenses, R&DS revenue grew 1.2 percent on a reported basis. Contract Sales & Medical Solutions (CSMS) revenue of $181 million decreased 4.2 percent on a reported basis and 2.1 percent at constant currency.

As of March 31, 2025, R&DS contracted backlog, including reimbursed expenses, was $31.5 billion, growing 4.8 percent year-over-year and 4.6 percent at constant currency. The company expects approximately $7.9 billion of this backlog to convert to revenue in the next twelve months. First quarter net new bookings were $2.1 billion, representing a book-to-bill ratio of 1.02x, and resulting in a trailing-twelve-month book-to-bill ratio of 1.14x.

First-quarter GAAP Net Income was $249 million and GAAP Diluted Earnings per Share was $1.40. Adjusted EBITDA was $883 million, up 2.4 percent year-over-year. Adjusted Net Income was $479 million and Adjusted Diluted Earnings per Share was $2.70, up 2.4 percent and 6.3 percent, respectively.

“IQVIA delivered strong revenue and profit performance, at the high-end of our expectations,” said Ari Bousbib, chairman and CEO of IQVIA. “In the clinical trial business, we experienced delayed decision-making by customers on new programs, reflecting incremental macroeconomic and industry sector uncertainty. Despite the environment, our R&DS forward-looking indicators such as qualified pipeline, RFP flow, and backlog continued to grow. On the commercial side, the TAS business delivered above target performance, with revenue growth of 7.6 percent at constant currency. Our strong financial results demonstrate that we are navigating the current market conditions more effectively than our sector, reflecting the scale and strength of our differentiated portfolio and the resilience of our operational execution.”

Financial Position

As of March 31, 2025, cash and cash equivalents were $1,740 million and debt was $14,330 million, resulting in net debt of $12,590 million. IQVIA’s Net Leverage Ratio was 3.40x trailing twelve-month Adjusted EBITDA. For the first quarter, Operating Cash Flow was $568 million and Free Cash Flow was $426 million.

Share Repurchase

During the first quarter of 2025, the company repurchased $425 million of its common stock. IQVIA had $2,588 million of share repurchase authorization remaining as of March 31, 2025.

Full-Year 2025 Guidance

To reflect the favorable change in foreign currency exchange rates since the company released its prior guidance, the company is raising its full-year 2025 revenue guidance to be between $16,000 million and $16,400 million. The company reaffirms its profit guidance of Adjusted EBITDA between $3,765 million and $3,885 million, and Adjusted Diluted Earnings per Share between $11.70 and $12.10.

All financial guidance assumes foreign currency exchange rates as of May 5, 2025 remain in effect for the forecast period.

Webcast & Conference Call Details

IQVIA will host a conference call at 9:00 a.m. Eastern Time today to discuss its first-quarter 2025 results and its second-quarter and full-year 2025 guidance. To listen to the event and view the presentation slides via webcast, join from the IQVIA Investor Relations website at http://ir.iqvia.com. To participate in the conference call, interested parties must register in advance by clicking on this link. Following registration, participants will receive a confirmation email containing details on how to join the conference call, including the dial-in and a unique passcode and registrant ID. At the time of the live event, registered participants connect to the call using the information provided in the confirmation email and will be placed directly into the call.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using artificial intelligence (“AI”) responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 89,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

Cautionary Statements Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, our full-year 2025 guidance. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “assume,” “anticipate,” “intend,” “plan,” “forecast,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from our expectations due to a number of factors, including, but not limited to, the following: business disruptions caused by natural disasters, pandemics such as the COVID-19 (coronavirus) outbreak, including any variants, and the public health policy responses to the outbreak, and international conflicts or other disruptions outside of our control; most of our contracts may be terminated on short notice, and we may lose or experience delays with large client contracts or be unable to enter into new contracts; the market for our services may not grow as we expect; we may be unable to successfully develop and market new services or enter new markets; imposition of restrictions on our use of data by data suppliers or their refusal to license data to us; any failure by us to comply with contractual, regulatory or ethical requirements under our contracts, including current or future changes to data protection and privacy laws; breaches or misuse of our or our outsourcing partners’ security or communications systems; failure to meet our productivity or business transformation objectives; failure to successfully invest in growth opportunities; our ability to protect our intellectual property rights and our susceptibility to claims by others that we are infringing on their intellectual property rights; the expiration or inability to acquire third party licenses for technology or intellectual property; any failure by us to accurately and timely price and formulate cost estimates for contracts, or to document change orders; hardware and software failures, delays in the operation of our computer and communications systems or the failure to implement system enhancements; the rate at which our backlog converts to revenue; our ability to acquire, develop and implement technology necessary for our business; consolidation in the industries in which our clients operate; risks related to client or therapeutic concentration; government regulators or our customers may limit the number or scope of indications for medicines and treatments or withdraw products from the market, and government regulators may impose new regulatory requirements or may adopt new regulations affecting the biopharmaceutical industry; the risks associated with operating on a global basis, including currency or exchange rate fluctuations and legal compliance, including anti-corruption laws; risks related to the enactment of legislation or the imposition of regulations or other restrictions or actions by governments that create business uncertainty and have the potential to limit trade; risks related to changes in accounting standards; general economic conditions in the markets in which we operate, including financial market conditions, inflation, and risks related to sales to government entities; the impact of changes in tax laws and regulations; and our ability to successfully integrate, and achieve expected benefits from, our acquired businesses. For a further discussion of the risks relating to our business, see the “Risk Factors” in our annual report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”), as such factors may be amended or updated from time to time in our subsequent periodic and other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC. We assume no obligation to update any such forward-looking statement after the date of this release, whether as a result of new information, future developments or otherwise.

Note on Non-GAAP Financial Measures

This release includes information based on financial measures that are not recognized under generally accepted accounting principles in the United States (“GAAP”), such as Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted Earnings per Share, Gross Leverage Ratio, Net Leverage Ratio and Free Cash Flow. Non-GAAP financial measures are presented only as a supplement to the company’s financial statements based on GAAP. Non-GAAP financial information is provided to enhance understanding of the company’s financial performance, but none of these non-GAAP financial measures are recognized terms under GAAP, and non-GAAP measures should not be considered in isolation from, or as a substitute analysis for, the company’s results of operations as determined in accordance with GAAP. The company uses non-GAAP measures in its operational and financial decision making, and believes that it is useful to exclude certain items in order to focus on what it regards to be a more meaningful indicator of the underlying operating performance of the business. For example, the company excludes all the amortization of intangible assets associated with acquired customer relationships and backlog, databases, non-compete agreements, trademarks and trade names from non-GAAP expense and income measures as such amounts can be significantly impacted by the timing and size of acquisitions. Although we exclude amortization of acquired intangible assets from our non-GAAP expenses, we believe that it is important for investors to understand that revenue generated from such intangibles is included within revenue in determining net income. As a result, internal management reports feature non-GAAP measures which are also used to prepare strategic plans and annual budgets and review management compensation. The company also believes that investors may find non-GAAP financial measures useful for the same reasons, although investors are cautioned that non-GAAP financial measures are not a substitute for GAAP disclosures.

The non-GAAP financial measures are not presented in accordance with GAAP. Please refer to the schedules attached to this release for reconciliations of non-GAAP financial measures contained herein to the most directly comparable GAAP measures. Our full-year 2025 guidance measures (other than revenue) are provided on a non-GAAP basis without a reconciliation to the most directly comparable GAAP measure because the company is unable to predict with a reasonable degree of certainty certain items contained in the GAAP measures without unreasonable efforts. For the same reasons, the company is unable to address the probable significance of the unavailable information. Such items include, but are not limited to, acquisition related expenses, restructuring and related expenses, stock-based compensation and other items not reflective of the company’s ongoing operations.

Non-GAAP measures are frequently used by securities analysts, investors and other interested parties in their evaluation of companies comparable to the company, many of which present non-GAAP measures when reporting their results. Non-GAAP measures have limitations as an analytical tool. They are not presentations made in accordance with GAAP, are not measures of financial condition or liquidity and should not be considered as an alternative to profit or loss for the period determined in accordance with GAAP or operating cash flows determined in accordance with GAAP. Non-GAAP measures are not necessarily comparable to similarly titled measures used by other companies. As a result, you should not consider such performance measures in isolation from, or as a substitute analysis for, the company’s results of operations as determined in accordance with GAAP.

IQVIAFIN

 

Table 1

IQVIA HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(preliminary and unaudited)

 

 

 

Three Months Ended March 31,

(in millions, except per share data)

 

 

2025

 

 

 

2024

 

Revenues

 

$

3,829

 

 

$

3,737

 

Cost of revenues, exclusive of depreciation and amortization

 

 

2,531

 

 

 

2,444

 

Selling, general and administrative expenses

 

 

508

 

 

 

508

 

Depreciation and amortization

 

 

265

 

 

 

264

 

Restructuring costs

 

 

29

 

 

 

15

 

Income from operations

 

 

496

 

 

 

506

 

Interest income

 

 

(11

)

 

 

(11

)

Interest expense

 

 

165

 

 

 

166

 

Loss on extinguishment of debt

 

 

4

 

 

 

 

Other expense, net

 

 

15

 

 

 

11

 

Income before income taxes and equity in losses of unconsolidated affiliates

 

 

323

 

 

 

340

 

Income tax expense

 

 

61

 

 

 

49

 

Income before equity in losses of unconsolidated affiliates

 

 

262

 

 

 

291

 

Equity in losses of unconsolidated affiliates

 

 

(13

)

 

 

(3

)

Net income

 

$

249

 

 

$

288

 

Earnings per share attributable to common stockholders:

 

 

 

 

Basic

 

$

1.42

 

 

$

1.58

 

Diluted

 

$

1.40

 

 

$

1.56

 

Weighted average common shares outstanding:

 

 

 

 

Basic

 

 

175.7

 

 

 

181.9

 

Diluted

 

 

177.4

 

 

 

184.3

 

 

Table 2

IQVIA HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(preliminary and unaudited)

 

(in millions, except per share data)

 

March 31, 2025

 

December 31, 2024

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

1,740

 

 

$

1,702

 

Trade accounts receivable and unbilled services, net

 

 

3,268

 

 

 

3,204

 

Prepaid expenses

 

 

166

 

 

 

154

 

Income taxes receivable

 

 

43

 

 

 

36

 

Investments in debt, equity and other securities

 

 

136

 

 

 

141

 

Other current assets and receivables

 

 

558

 

 

 

592

 

Total current assets

 

 

5,911

 

 

 

5,829

 

Property and equipment, net

 

 

533

 

 

 

535

 

Operating lease right-of-use assets

 

 

235

 

 

 

238

 

Investments in debt, equity and other securities

 

 

130

 

 

 

108

 

Investments in unconsolidated affiliates

 

 

253

 

 

 

266

 

Goodwill

 

 

15,027

 

 

 

14,710

 

Other identifiable intangibles, net

 

 

4,503

 

 

 

4,499

 

Deferred income taxes

 

 

245

 

 

 

194

 

Deposits and other assets, net

 

 

485

 

 

 

520

 

Total assets

 

$

27,322

 

 

$

26,899

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable and accrued expenses

 

$

3,559

 

 

$

3,684

 

Unearned income

 

 

1,940

 

 

 

1,779

 

Income taxes payable

 

 

139

 

 

 

156

 

Current portion of long-term debt

 

 

1,222

 

 

 

1,145

 

Other current liabilities

 

 

319

 

 

 

193

 

Total current liabilities

 

 

7,179

 

 

 

6,957

 

Long-term debt, less current portion

 

 

13,108

 

 

 

12,838

 

Deferred income taxes

 

 

197

 

 

 

196

 

Operating lease liabilities

 

 

177

 

 

 

173

 

Other liabilities

 

 

676

 

 

 

668

 

Total liabilities

 

 

21,337

 

 

 

20,832

 

Commitments and contingencies

 

 

 

 

Stockholders’ equity:

 

 

 

 

Common stock and additional paid-in capital, 400.0 shares authorized as of March 31, 2025 and December 31, 2024, $0.01 par value, 258.5 shares issued and 174.1 shares outstanding as of March 31, 2025; 258.2 shares issued and 176.1 shares outstanding as of December 31, 2024

 

 

11,173

 

 

 

11,143

 

Retained earnings

 

 

6,314

 

 

 

6,065

 

Treasury stock, at cost, 84.4 and 82.1 shares as of March 31, 2025 and December 31, 2024, respectively

 

 

(10,532

)

 

 

(10,103

)

Accumulated other comprehensive loss

 

 

(978

)

 

 

(1,038

)

Equity attributable to IQVIA Holdings Inc.’s stockholders

 

 

5,977

 

 

 

6,067

 

Noncontrolling interests

 

 

8

 

 

 

 

Total stockholders’ equity

 

 

5,985

 

 

 

6,067

 

Total liabilities and stockholders’ equity

 

$

27,322

 

 

$

26,899

 

 

Table 3

IQVIA HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(preliminary and unaudited)

 

 

 

Three Months Ended March 31,

(in millions)

 

 

2025

 

 

 

2024

 

Operating activities:

 

 

 

 

Net income

 

$

249

 

 

$

288

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

 

265

 

 

 

264

 

Amortization of debt issuance costs and discount

 

 

5

 

 

 

5

 

Stock-based compensation

 

 

72

 

 

 

56

 

Losses from unconsolidated affiliates

 

 

13

 

 

 

3

 

Loss (gain) on investments, net

 

 

1

 

 

 

(12

)

Benefit from deferred income taxes

 

 

(41

)

 

 

(66

)

Changes in operating assets and liabilities:

 

 

 

 

Change in accounts receivable, unbilled services and unearned income

 

 

128

 

 

 

65

 

Change in other operating assets and liabilities

 

 

(124

)

 

 

(81

)

Net cash provided by operating activities

 

 

568

 

 

 

522

 

Investing activities:

 

 

 

 

Acquisition of property, equipment and software

 

 

(142

)

 

 

(145

)

Acquisition of businesses, net of cash acquired

 

 

(134

)

 

 

(142

)

Sales (purchases) of marketable securities, net

 

 

2

 

 

 

(1

)

Investments in unconsolidated affiliates, net of payments received

 

 

(13

)

 

 

(24

)

Investments in debt and equity securities

 

 

(19

)

 

 

(2

)

Other

 

 

1

 

 

 

 

Net cash used in investing activities

 

 

(305

)

 

 

(314

)

Financing activities:

 

 

 

 

Proceeds from issuance of debt

 

 

1,985

 

 

 

 

Payment of debt issuance costs

 

 

(6

)

 

 

 

Repayment of debt and principal payments on finance leases

 

 

(2,096

)

 

 

(43

)

Proceeds from revolving credit facility

 

 

275

 

 

 

275

 

Repayment of revolving credit facility

 

 

 

 

 

(275

)

Payments related to employee stock incentive plans

 

 

(35

)

 

 

(60

)

Repurchase of common stock

 

 

(375

)

 

 

 

Contingent consideration and deferred purchase price payments

 

 

(6

)

 

 

(3

)

Net cash used in financing activities

 

 

(258

)

 

 

(106

)

Effect of foreign currency exchange rate changes on cash

 

 

33

 

 

 

(34

)

Increase in cash and cash equivalents

 

 

38

 

 

 

68

 

Cash and cash equivalents at beginning of period

 

 

1,702

 

 

 

1,376

 

Cash and cash equivalents at end of period

 

$

1,740

 

 

$

1,444

 

 

Table 4

IQVIA HOLDINGS INC. AND SUBSIDIARIES

NET INCOME TO ADJUSTED EBITDA RECONCILIATION

(preliminary and unaudited)

 

 

 

Three Months Ended March 31,

(in millions)

 

 

2025

 

 

 

2024

 

Net Income

 

$

249

 

$

288

Provision for income taxes

 

 

61

 

 

 

49

 

Depreciation and amortization

 

 

265

 

 

 

264

 

Interest expense, net

 

 

154

 

 

 

155

 

Loss in unconsolidated affiliates

 

 

13

 

 

 

3

 

Stock-based compensation

 

 

72

 

 

 

56

 

Other expense, net (1)

 

 

15

 

 

 

21

 

Loss on extinguishment of debt

 

 

4

 

 

 

 

Restructuring and related expenses (2)

 

 

42

 

 

 

22

 

Acquisition related expenses

 

 

8

 

 

 

4

 

Adjusted EBITDA

 

$

883

 

 

$

862

 

(1)

Reflects certain non-operating income items, revaluations of contingent consideration and certain non-recurring expenses.

(2)

Reflects restructuring costs as well as accelerated expenses related to lease exits.

 

Table 5

IQVIA HOLDINGS INC. AND SUBSIDIARIES

NET INCOME TO ADJUSTED NET INCOME RECONCILIATION

(preliminary and unaudited)

 

 

 

Three Months Ended March 31,

(in millions, except per share data)

 

 

2025

 

 

 

2024

 

Net Income

 

$

249

 

 

$

288

 

Provision for income taxes

 

 

61

 

 

 

49

 

Purchase accounting amortization (1)

 

 

125

 

 

 

129

 

Loss in unconsolidated affiliates

 

 

13

 

 

 

3

 

Stock-based compensation

 

 

72

 

 

 

56

 

Other expense, net (2)

 

 

15

 

 

 

21

 

Loss on extinguishment of debt

 

 

4

 

 

 

 

Restructuring and related expenses (3)

 

 

42

 

 

 

22

 

Acquisition related expenses

 

 

8

 

 

 

4

 

Adjusted Pre Tax Income

 

$

589

 

 

$

572

 

Adjusted tax expense

 

 

(110

)

 

 

(104

)

Adjusted Net Income

 

$

479

 

 

$

468

 

 

 

 

 

 

Adjusted earnings per share attributable to common stockholders:

 

 

 

 

Basic

 

$

2.73

 

 

$

2.57

 

Diluted

 

$

2.70

 

 

$

2.54

 

Weighted average common shares outstanding:

 

 

 

 

Basic

 

 

175.7

 

 

 

181.9

 

Diluted

 

 

177.4

 

 

 

184.3

 

(1)

Reflects all the amortization of acquired intangible assets.

(2)

Reflects certain non-operating income items, revaluations of contingent consideration and certain non-recurring expenses.

(3)

Reflects restructuring costs as well as accelerated expenses related to lease exits.

 

Table 6

IQVIA HOLDINGS INC. AND SUBSIDIARIES

NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW RECONCILIATION

(preliminary and unaudited)

 

(in millions)

 

Three Months Ended

March 31, 2025

 

Three Months Ended

March 31, 2024

Net Cash provided by Operating Activities

 

$

568

 

 

$

522

 

Acquisition of property, equipment and software

 

 

(142

)

 

 

(145

)

Free Cash Flow

 

$

426

 

 

$

377

 

 

Table 7

IQVIA HOLDINGS INC. AND SUBSIDIARIES

CALCULATION OF GROSS AND NET LEVERAGE RATIOS

AS OF MARCH 31, 2025

(preliminary and unaudited)

 

(in millions)

 

 

Gross Debt, net of Unamortized Discount and Debt Issuance Costs, as of March 31, 2025

 

$

14,330

Net Debt as of March 31, 2025

 

$

12,590

 

Adjusted EBITDA for the twelve months ended March 31, 2025

 

$

3,705

 

Gross Leverage Ratio (Gross Debt/LTM Adjusted EBITDA)

 

3.87x

Net Leverage Ratio (Net Debt/LTM Adjusted EBITDA)

 

3.40x

 

Kerri Joseph, IQVIA Investor Relations ([email protected])

+1.973.541.3558

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Technology Security Health Technology Software Biotechnology Health General Health Data Management Artificial Intelligence

MEDIA:

Logo
Logo

GlobalFoundries Reports First Quarter 2025 Financial Results

MALTA, N.Y., May 06, 2025 (GLOBE NEWSWIRE) — GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the first quarter ended March 31, 2025.

Key First Quarter Financial Highlights

  • Revenue of $1.585 billion
  • Gross margin of 22.4% and Non-IFRS gross margin(1) of 23.9%
  • Operating margin of 9.5% and Non-IFRS operating margin(1) of 13.4%
  • Net income of $211 million and Non-IFRS net income(1) of $189 million
  • Diluted earnings per share of $0.38 and Non-IFRS diluted earnings per share(1) of $0.34
  • Non-IFRS adjusted EBITDA(1) of $558 million
  • Ending cash, cash equivalents and marketable securities of $3.7 billion
  • Net cash provided by operating activities of $331 million and Non-IFRS adjusted free cash flow(1) of $165 million

“In the first quarter, the GF team delivered strong financial results at the high end of the Non-IFRS guidance ranges for revenue, gross margin, and earnings per share,” said Tim Breen, CEO of GF. “A testament to our solid execution, operational excellence, and robust design wins, our Automotive, Communications Infrastructure and Datacenter, and Home and Industrial IoT end markets grew year over year in the first quarter. From autonomous vehicles to satellite communications to optical networking, GF continues to build momentum in critical applications with robust growth prospects.”

Recent Business Highlights

  • GF and indie Semiconductor announced a strategic partnership to develop high-performance radar systems-on-chip (SoC). Built on GF’s automotive-qualified 22FDX® platform, these solutions will target 77 GHz and 120 GHz radar applications to enable safety-critical advanced driver assistance systems with low cost, small footprint, and efficient power consumption.
  • Ayar Labs announced that the industry’s first Universal Chiplet Interconnect Express (UCIe) optical interconnect chiplet will utilize GF’s monolithic photonics platform. GF’s technology uniquely enables Ayar Lab’s solution to enhance AI infrastructure performance by driving high-speed data over long distances, while reducing latency and power consumption.
  • In April, Bosch announced at Auto Shanghai the launch of its next generation single chip radar sensor, which reliably, precisely, and quickly detects objects for assisted and automated driving. As previously announced, GF continues its partnership with Bosch, enabling this high-performance, high-efficiency automotive radar technology with GF’s 22FDX platform.


(
1
) See “Reconciliation of IFRS to Non-IFRS” for a detailed reconciliation of Non-IFRS financial measures to the most directly comparable IFRS measure. See “Financial Measures (Non-IFRS)” for further discussion on these Non-IFRS measures and why we believe they are useful.

 
GLOBALFOUNDRIES Inc.

Summary Quarterly Results

(Unaudited, in millions, except per share amounts and wafer shipments)

 
                Year-over-year   Sequential
   
Q1’25
 
Q4’24
 
Q1’24
 
Q1’25 vs Q1’24
 
Q1’25 vs Q4’24
                             
Net revenue   $ 1,585     $ 1,830     $ 1,549     $ 36     2 %   $ (245 )   (13 )%
                             
Gross profit   $ 355     $ 449     $ 393     $ (38 )   (10 )%   $ (94 )   (21 )%
Gross margin     22.4 %     24.5 %     25.4 %       (300)bps       (210)bps
                             
Non-IFRS gross profit

(


1


)
  $ 379     $ 464     $ 405     $ (26 )   (6 )%   $ (85 )   (18 )%
Non-IFRS gross margin

(


1


)
    23.9 %     25.4 %     26.1 %       (220)bps       (150)bps
                             
Operating profit (loss)   $ 151     $ (701 )   $ 147     $ 4     3 %   $ 852     122 %
Operating (loss) margin     9.5 %   (38.3 )%     9.5 %       0bps       +4,780bps
                             
Non-IFRS operating profit

(


1


)
  $ 213     $ 285     $ 187     $ 26     14 %   $ (72 )   (25 )%
Non-IFRS operating margin

(


1


)
    13.4 %     15.6 %     12.1 %       +130bps       (220)bps
                             
Net income (loss)   $ 211     $ (729 )   $ 134     $ 77     57 %   $ 940     129 %
Net income (loss) margin     13.3 %   (39.8 )%     8.7 %       +460bps       +5,310bps
                             
Non-IFRS net income

(1)
  $ 189     $ 256     $ 174     $ 15     9 %   $ (67 )   (26 )%
Non-IFRS net income margin

(1)
    11.9 %     14.0 %     11.2 %       +70bps       (210)bps
                             
Diluted earnings (loss) per share (“EPS”)   $ 0.38     $ (1.32 )   $ 0.24     $ 0.14     58 %   $ 1.70     129 %
                             
Non-IFRS diluted EPS

(


1


)
  $ 0.34     $ 0.46     $ 0.31     $ 0.03     10 %   $ (0.12 )   (26 )%
                             
Non-IFRS adjusted EBITDA

(1)
  $ 558     $ 661     $ 577     $ (19 )   (3 )%   $ (103 )   (16 )%
Non-IFRS adjusted EBITDA margin

(1)
    35.2 %     36.1 %     37.2 %       (200)bps       (90)bps
                             
Cash from operating activities   $ 331     $ 457     $ 488     $ (157 )   (32 )%   $ (126 )   (28 )%
                             
Wafer shipments (300mm equivalent)

(in thousands)
    543       595       463       80     17 %     (52 )   (9 )%
                             


(
1
) See “Reconciliation of IFRS to Non-IFRS” for a detailed reconciliation of Non-IFRS financial measures to the most directly comparable IFRS measure. See “Financial Measures (Non-IFRS)” for further discussion on these Non-IFRS measures and why we believe they are useful.

 
GLOBALFOUNDRIES Inc.

Summary of Second Quarter 2025 Guidance

(1)


(
Unaudited, in millions, except per share amounts)

 
  IFRS   Share-based
compensation


(3)
  Non-IFRS

(2)
Net revenue $1,675 ± $25        
Gross margin

(


2


)
24.1% ± 100bps   ~90bps   25.0% ± 100bps
Operating expenses $222 ± $10   ~$37   $185 ± $10
Operating margin

(


2


)
10.8% ± 180bps   ~320bps   14.0% ± 180bps
Diluted EPS

(2)



(4)

$0.27 ± $0.06   ~$0.09   $0.36 ± $0.05
Fully Diluted Share Count ~560        
           


(1) The Guidance provided contains forward-looking statements as defined in the U.S. Private Securities Litigation Act of 1995, and is subject to the safe harbors created therein. The Guidance includes management’s beliefs and assumptions and is based on information that is available as of the date of this release.


(2) Non-IFRS gross margin, Non-IFRS operating margin, Non-IFRS operating expenses and Non-IFRS diluted EPS are Non-IFRS measures and, for purposes of the Guidance only, are defined as gross profit as a percent of revenue, operating profit as a percent of revenue, operating expenses and diluted EPS, all before share-based compensation, respectively. See “Financial Measures (Non-IFRS)” for further discussion on these Non-IFRS measures and why we believe they are useful.


(3) We expect share-based compensation of $15 million and $37 million in cost of revenue and operating expenses, respectively. The Non-IFRS margin impacts are calculated by dividing share-based compensation by net revenue, and the Non-IFRS diluted EPS impact is calculated by dividing share-based compensation by the fully diluted share count.


(
4
) Included in diluted EPS is net interest income (expense) and other income (expense) which we estimate will be between $3 million and $11 million for the second quarter 2025. Also included in diluted EPS is income tax expense which we estimate will be between $33 million and $47 million for the second quarter 2025.

 
GLOBALFOUNDRIES Inc.

Consolidated Statements of Operations

(Unaudited, in millions, except for per share amounts)

 
    Three Months Ended
    March 31, 2025   March 31, 2024
         
Net revenue   $ 1,585     $ 1,549  
Cost of revenue     1,230       1,156  
Gross profit   $ 355     $ 393  
Operating expenses:        
Research and development     127       124  
Selling, general and administrative     77       122  
Total operating expenses   $ 204     $ 246  
Operating profit   $ 151     $ 147  
Finance income (expense), net     14       10  
Other income (expense)     30       (2 )
Income tax (expense) benefit     16       (21 )
Net income   $ 211     $ 134  
Attributable to:        
Shareholders of GLOBALFOUNDRIES Inc.     210       133  
Non-controlling interest     1       1  
EPS:        
Basic   $ 0.38     $ 0.24  
Diluted   $ 0.38     $ 0.24  
Shares used in EPS calculation:        
Basic     554       555  
Diluted     557       558  

 
GLOBALFOUNDRIES Inc.

Condensed Consolidated Statements of Financial Position

(Unaudited, in millions)

 
    March 31, 2025   December 31, 2024
         
Assets:        
Cash and cash equivalents   $ 1,596     $ 2,192  
Marketable securities     1,281       1,194  
Receivables, prepayments and other     1,415       1,406  
Inventories     1,813       1,624  
Current assets   $ 6,105     $ 6,416  
Property, plant and equipment, net   $ 7,626     $ 7,762  
Marketable securities     820       839  
Right-of-use assets     499       498  
Deferred tax assets     250       188  
Other assets     1,179       1,096  
Non-current assets   $ 10,374     $ 10,383  
Total assets   $ 16,479     $ 16,799  
Liabilities and equity:        
Current portion of long-term debt   $ 57     $ 753  
Other current liabilities     2,371       2,291  
Current liabilities   $ 2,428     $ 3,044  
Non-current portion of long-term debt   $ 1,071     $ 1,053  
Non-current portion of lease obligations     426       424  
Other liabilities     1,450       1,454  
Non-current liabilities   $ 2,947     $ 2,931  
Total liabilities   $ 5,375     $ 5,975  
Shareholders’ equity:        
Common stock / additional paid-in capital   $ 24,057     $ 24,025  
Accumulated deficit     (13,056 )     (13,266 )
Accumulated other comprehensive income     53       17  
Non-controlling interest     50       48  
Total liabilities and equity   $ 16,479     $ 16,799  

 
GLOBALFOUNDRIES Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited, in millions)

 
    Three Months Ended
    March 31,

2025
  March 31,

2024
         
Operating Activities:        
Net income   $ 211     $ 134  
Depreciation and amortization     352       392  
Finance (income) expense, net and other     9       6  
Net change in working capital     (144 )     (97 )
Other non-cash operating activities     (97 )     53  
Net cash provided by operating activities   $ 331     $ 488  
         
Investing Activities:        
Purchases of property, plant and equipment and intangible assets   $ (166 )   $ (227 )
Acquisition of joint venture interest, net of cash acquired     (19 )      
Net purchases of marketable securities     (61 )     (371 )
Other investing activities     35       (2 )
Net cash used in investing activities   $ (211 )   $ (600 )
         
Financing Activities:        
Proceeds from issuance of equity instruments   $ 16     $ 23  
Proceeds (repayment) of debt, net     (733 )     (50 )
Net cash used in financing activities   $ (717 )   $ (27 )
Effect of exchange rate changes     1       (1 )
Net change in cash and cash equivalents   $ (596 )   $ (140 )
Cash and cash equivalents at the beginning of the period     2,192       2,387  
Cash and cash equivalents at the end of the period   $ 1,596     $ 2,247  

 
GLOBALFOUNDRIES Inc.

Reconciliation of IFRS to Non-IFRS

(Unaudited, in millions, except for per share amounts)

 
  Three Months Ended March 31, 2025
    Gross
profit
  Selling,
General &
Administrative
  Research &
Development
  Operating
profit
  Other
Income
(Expense)
  Income tax
(expense)
benefit
  Net
income
  Diluted
EPS
As Reported   $ 355     $ 77     $ 127     $ 151     $ 30     $ 16     $ 211     $ 0.38  
IFRS margins

(1)
    22.4 %             9.5 %             13.3 %    
Share-based compensation     13       (20 )     (7 )     40             (2 )     38       0.07  
Structural optimization(2)     11       (5 )     (5 )     21             (3 )     18       0.03  
Amortization of acquired intangibles and other acquisition related charges                 (1 )     1       (31 )     6       (24 )     (0.04 )
Revaluation of equity investments                             (6 )           (6 )     (0.01 )
Tax matters(3)                                   (48 )     (48 )     (0.09 )
Non-IFRS measures

(1)
  $ 379     $ 52     $ 114     $ 213     $ (7 )   $ (31 )   $ 189     $ 0.34  
Non-IFRS margins

(1)
    23.9 %             13.4 %             11.9 %    

  Three Months Ended December 31, 2024
    Gross
profit
  Selling,
General &
Administrative
  Research &
Development
  Operating
profit
  Other
Income
(Expense)
  Income tax
(expense)
benefit
  Net
income
  Diluted
EPS
As Reported   $ 449     $ 93     $ 121     $ (701 )   $ (1 )   $ (42 )   $ (729 )   $ (1.32 )
IFRS margins

(1)
    24.5 %           (38.3 )%           (39.8 )%    
Share-based compensation     15       (22 )     (8 )     45                   45       0.09  
Structural optimization(2)           (2 )     (1 )     3             (1 )     2       0.01  
Amortization of acquired intangibles and other acquisition related charges                 (2 )     2                   2        
Impairment of long-lived assets                       935                   935       1.68  
Restructuring charges                       1                   1        
Non-IFRS measures

(1)
  $ 464     $ 69     $ 110     $ 285     $ (1 )   $ (43 )   $ 256     $ 0.46  
Non-IFRS margins

(1)
    25.4 %             15.6 %             14.0 %    

  Three Months Ended March 31, 2024
    Gross
profit
  Selling,
General &
Administrative
  Research &
Development
  Operating
profit
  Other
Income
(Expense)
  Income tax
(expense)
benefit
  Net
income
  Diluted
EPS
As Reported   $ 393     $ 122     $ 124     $ 147     $ (2 )   $ (21 )   $ 134     $ 0.24  
IFRS margins

(1)
    25.4 %             9.5 %             8.7 %    
Share based compensation     12       (21 )     (7 )     40                   40       0.07  
Non-IFRS measures

(1)
  $ 405     $ 101     $ 117     $ 187     $ (2 )   $ (21 )   $ 174     $ 0.31  
Non-IFRS margins

(1)
    26.1 %             12.1 %             11.2 %    
                                             


(
1
) See “Financial Measures (Non-IFRS)” for further discussion on these Non-IFRS measures and why we believe they are useful.


(
2
) Structural optimization represents costs associated with employee workforce reduction and manufacturing footprint alignment.


(
3
) Comprised of net deferred tax asset recognition and foreign exchange rate impact.

 
GLOBALFOUNDRIES Inc.

Reconciliation of IFRS to Non-IFRS

Non-IFRS Adjusted Free Cash Flow

(1)


(Unaudited, in millions
)

 
    Three Months Ended
    March 31, 2025   December 31, 2024   March 31, 
2024
             
Net cash provided by operating activities   $ 331     $ 457     $ 488  
Less: Purchases of property, plant and equipment and intangible assets     (166 )     (135 )     (227 )
Add: Proceeds from government grants           6        
Non-IFRS adjusted free cash
flow

(1)
  $ 165     $ 328     $ 261  
                         


(1) See “Financial Measures (Non-IFRS)” for further discussion on this Non-IFRS measure and why we believe it is useful.

 
Reconciliation of IFRS to Non-IFRS

Non-IFRS Adjusted EBITDA

(


1


)


(Unaudited, in millions)

 
    Three Months Ended
    March 31, 
2025
  December 31, 2024   March 31, 2024
             
Net revenue   $ 1,585     $ 1,830     $ 1,549  
Net income (loss)     211       (729 )     134  
Net income (loss) margin     13.3 %   (39.8 )%     8.7 %
Depreciation and amortization     352       378       392  
Finance expense     25       34       37  
Finance income     (39 )     (49 )     (47 )
Income tax expense (benefit)     (16 )     42       21  
Share-based compensation     40       45       40  
Restructuring charges           1        
Impairment of long-lived assets           935        
Structural optimization     21       3        
Revaluation of equity investments     (6 )            
Other acquisition related charges     (30 )     1        
Non-IFRS adjusted EBITDA


(1)

  $ 558     $ 661     $ 577  
Non-IFRS adjusted EBITDA margin

(1)
    35.2 %     36.1 %     37.2 %
                         


(
1
) See “Financial Measures (Non-IFRS)” for further discussion on this Non-IFRS measure and why we believe it is useful.



GLOBALFOUNDRIES Inc.


Financial Measures (Non-IFRS)

In addition to the financial information presented in accordance with International Financial Reporting Standards (“IFRS”), this press release includes the following Non-IFRS financial measures: Non-IFRS gross profit, Non-IFRS operating profit, Non-IFRS operating expense, Non-IFRS net income, Non-IFRS selling, general and administrative, Non-IFRS research and development, Non-IFRS other income (expense), Non-IFRS income tax benefit (expense), Non-IFRS diluted earnings per share (“EPS”), Non-IFRS adjusted EBITDA, Non-IFRS adjusted free cash flow and any related margins. We define each of Non-IFRS gross profit, Non-IFRS selling, general and administrative, Non-IFRS research and development, Non-IFRS operating profit, Non-IFRS other income (expense), Non-IFRS income tax benefit (expense) and Non-IFRS net income as gross profit, selling, general and administrative, research and development, operating profit, other income (expense), income tax benefit (expense), and net income, respectively, adjusted for share-based compensation, structural optimization, amortization of acquired intangibles and other acquisition related charges, impairment of long-lived assets, revaluation of equity investments, restructuring charges, tax matters, and any associated income tax effects. We define Non-IFRS operating expense as Non-IFRS gross profit minus Non-IFRS operating profit. We define Non-IFRS diluted EPS as Non-IFRS net income divided by the diluted shares outstanding. We define Non-IFRS adjusted free cash flow as cash flow provided by (used in) operating activities less purchases of property, plant and equipment and intangible assets plus proceeds from government grants related to capital expenditures. We define Non-IFRS adjusted EBITDA as net income adjusted for the impact of finance expense, finance income, income tax expense (benefit), depreciation and amortization, share-based compensation, restructuring charges, impairment of long-lived assets; revaluation of equity investments, structural optimization and acquisition related charges. We define each of Non-IFRS gross margin, Non-IFRS operating margin, Non-IFRS net income margin and Non-IFRS adjusted EBITDA margin as Non-IFRS gross profit, Non-IFRS operating profit, Non-IFRS net income and Non-IFRS adjusted EBITDA, respectively, divided by net revenue. Any adjustments described above that are zero for a given period are excluded from the “Reconciliation of IFRS to Non-IFRS” table. See “Reconciliation of IFRS to Non-IFRS” section for a detailed reconciliation of Non-IFRS financial measures to the most directly comparable IFRS measure.

We believe that in addition to our results determined in accordance with IFRS, these Non-IFRS financial measures provide useful information to both management and investors in measuring our financial performance and highlight trends in our business that may not otherwise be apparent when relying solely on IFRS measures. These Non-IFRS financial measures provide supplemental information regarding our operating performance that excludes certain gains, losses and non-cash charges that occur relatively infrequently and/or that we consider to be unrelated to our core operations. Management believes that Non-IFRS adjusted free cash flow as a Non-IFRS measure is helpful to investors as it provides insights into the nature and amount of cash the Company generates in the period.

Non-IFRS financial information is presented for supplemental informational purposes only and should not be considered in isolation or as a substitute for financial information presented in accordance with IFRS. Our presentation of Non-IFRS measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. Other companies in our industry may calculate these measures differently, which may limit their usefulness as comparative measures.


Conference Call and Webcast Information

GF will host a conference call with the financial community on Tuesday, May 6, 2025 at 8:30 a.m. U.S. Eastern Time (ET) to review the first quarter 2025 results in detail. Interested parties may join the scheduled conference call by registering at https://edge.media-server.com/mmc/p/jgpem5gd/.

The call will be webcast and can be accessed from the GF Investor Relations website https://investors.gf.com. A replay of the call will be available on the GF Investor Relations website within 24 hours of the actual call.


About GlobalFoundries

GlobalFoundries® (GF®) is one of the world’s leading semiconductor manufacturers. GF is redefining innovation and semiconductor manufacturing by developing and delivering feature-rich process technology solutions that provide leadership performance in pervasive high growth markets. GF offers a unique mix of design, development and fabrication services. With a talented and diverse workforce and an at-scale manufacturing footprint spanning the U.S., Europe and Asia, GF is a trusted technology source to its worldwide customers. For more information, visit www.gf.com.


Forward-looking Statements and Third Party Data

This press release includes “forward-looking statements” that reflect our current expectations and views of future events. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995 and include but are not limited to, statements regarding our financial outlook, future guidance, product development, business strategy and plans, and market trends, opportunities and positioning. These statements are based on current expectations, assumptions, estimates, forecasts, projections and limited information available at the time they are made. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “might,” “could,” “intend,” “shall,” “outlook,” “on track” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to a broad variety of risks and uncertainties, both known and unknown. Any inaccuracy in our assumptions and estimates could affect the realization of the expectations or forecasts in these forward-looking statements. For example, our business could be impacted by geopolitical conditions such as the ongoing political and trade tensions with China and the continuation of conflicts in Ukraine and Israel; political developments following the change in the U.S. administration; the imposition of trade controls, tariffs and counter-tariffs between the United States and its trade partners; the market for our products may develop or recover more slowly than expected or than it has in the past; we may fail to achieve the full benefits of our restructuring plan; our operating results may fluctuate more than expected; there may be significant fluctuations in our results of operations and cash flows related to our revenue recognition or otherwise; a network or data security incident that allows unauthorized access to our network or data or our customers’ data could result in a system disruption, loss of data or damage our reputation; we could experience interruptions or performance problems associated with our technology, including a service outage; global economic conditions could deteriorate, including due to rising inflation and any potential recession; the expected benefits of our announced partnerships may fail to materialize; and our expected results and planned expansions and operations may not proceed as planned if funding we expect to receive (including the planned awards under the U.S. CHIPS and Science Act and New York State Green CHIPS) is delayed or withheld for any reason. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results or outcomes to differ materially from those contained in any forward-looking statements we may make. Moreover, we operate in a competitive and rapidly changing market, and new risks may emerge from time to time. You should not rely upon forward-looking statements as predictions of future events. These statements are based on our historical performance and on our current plans, estimates and projections in light of information currently available to us, and therefore you should not place undue reliance on them.
Although we believe that the expectations reflected in our statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. Moreover, neither we, nor any other person, assumes responsibility for the accuracy and completeness of these statements. Recipients are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date such statements are made and should not be construed as statements of fact. Except to the extent required by federal securities laws, we undertake no obligation to update any information or any forward-looking statements as a result of new information, subsequent events or any other circumstances after the date hereof, or to reflect the occurrence of unanticipated events. For a discussion of potential risks and uncertainties, please refer to the risk factors and cautionary statements in our 2024 Annual Report on Form 20-F, current reports on Form 6-K and other reports filed with the Securities and Exchange Commission (SEC). Copies of our SEC filings are available on our Investor Relations website, investors.gf.com, or from the SEC website, www.sec.gov.


For further information, please contact:


                 
Investor Relations
[email protected]



ReposiTrak Adds 50 Nut Butter Product Suppliers to the Queue for the Rapidly Expanding Food Traceability Network

ReposiTrak Adds 50 Nut Butter Product Suppliers to the Queue for the Rapidly Expanding Food Traceability Network

Ahead of regulatory deadlines, 50 nut butter product suppliers are queued to join ReposiTrak for its innovative, hardware-free traceability solutions

SALT LAKE CITY–(BUSINESS WIRE)–
ReposiTrak (NYSE:TRAK), the world’s largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock reduction SaaS platform, is proud to add 50 nut butter product suppliers to the queue of companies joining the ReposiTrak Traceability Network® (RTN). These companies will efficiently exchange intricate, FDA-required Key Data Elements (KDEs) for each Critical Tracking Event (CTE) in their supply chains, with the goal of meeting traceability requirements before the FDA’s 2028 deadline.

Among the 50 new nut butter product suppliers are many with a rich history. One is a fourth-generation family farm in California’s Central Valley, known for its walnuts and innovative nut butters. Another is a Chicago-area producer specializing in raw, organic chocolate and superfoods. A third is an Austin-based company offering plant-based, certified organic snack bars and cookies made with simple, clean ingredients.

“In order to do the required recordkeeping, retailers would need to identify every nut butter-containing product and work with suppliers to collect the data for every shipment. That could take months, and there’s still a good chance the data will contain errors or omissions,” stated Randy Fields, chairman and CEO of ReposiTrak. “Many retailers have opted to use ReposiTrak to collect traceability data for ALL FOODS, so that no foods are missed. We do the supplier setup and error detection, and the retailer gets data that’s as complete and accurate as possible.”

The ReposiTrak Traceability Network requires no additional hardware or software and the ReposiTrak team assists in making the connections needed under the new regulation. Suppliers can connect to an unlimited number of trading partners and share data for a low, flat fee.

About ReposiTrak

ReposiTrak (NYSE: TRAK) provides retailers, suppliers, food manufacturers and wholesalers with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements, enhance operational controls and increase sales with unrivaled brand protection. Consisting of three product families – food traceability, compliance and risk management and supply chain solutions – ReposiTrak’s integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, please visit https://repositrak.com.

Investor Relations Contact:

John Merrill, CFO

[email protected]

Or

FNK IR

Rob Fink

646.809.4048

[email protected]

KEYWORDS: United States North America Utah

INDUSTRY KEYWORDS: Technology Software Networks Food/Beverage Internet Retail Data Management Supply Chain Management Food Tech

MEDIA:

Logo
Logo

CECO Environmental Announces Upcoming Investor Conferences

ADDISON, Texas, May 06, 2025 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces that CECO management will participate at the following investor conferences:

  • May 13, 2025 – The ONE Houlihan Lokey Global Industrials Conference
  • May 28, 2025 – The 22nd Annual Craig-Hallum Institutional Investor Conference in Minneapolis.
  • June 10, 2025 – The Wells Fargo 2025 Industrials Conference in Chicago (To be confirmed)
  • June 12, 2025 – The 15th Annual East Coast IDEAS Conference in New York.  
  • June 25, 2025 – The Northland Growth Virtual Conference
  • June 24-26, 2025 – The 15th Annual ROTH London Conference

The presentations will be available on the Investor Relations section of the Company’s website www.cecoenviro.com.

ABOUT CECO ENVIRONMENTAL

CECO Environmental is a leading environmentally focused, diversified industrial company, serving a broad landscape of industrial air, industrial water, and energy transition markets globally through its key business segments: Engineered Systems and Industrial Process Solutions. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean, and more efficient solutions that help protect people, the environment and industrial equipment. In regions around the world, CECO works to improve air quality, optimize the energy value chain, and provide custom solutions for applications in power generation, petrochemical processing, refining, midstream gas transport and treatment, electric vehicle and battery production, metals and mineral processing, polysilicon production, battery recycling, beverage can production, and produced and oily water/wastewater treatment along with a wide range of other industrial applications. CECO is listed on Nasdaq under the ticker symbol “CECO.” Incorporated in 1966, CECO’s global headquarters is in Addison, Texas. For more information, please visit www.cecoenviro.com.

Company Contact:

Peter Johansson
Chief Financial and Strategy Officer
888-990-6670
        
Investor Relations Contact:
Steven Hooser and Jean Marie Young
Three Part Advisors
214-872-2710
[email protected]



LCI Industries Reports First Quarter Financial Results

LCI Industries Reports First Quarter Financial Results

Operational flexibility, strategic diversification, and effective cost management drove profitable growth

First Quarter 2025 Highlights

  • Net sales of $1 billion in the first quarter, up 8% year-over-year
  • Net income of $49.4 million, which was 4.7% of net sales, or $1.94 per diluted share, in the first quarter, up 35% from the first quarter of 2024
  • Net income, as adjusted for the loss on extinguishment of debt, was $55.6 million, or $2.19 per diluted share, in the first quarter, up 52% from the first quarter of 2024
  • Adjusted EBITDA of $110.9 million, or 10.6% of net sales, in the first quarter, up 23% year-over-year
  • Operating profit margin of 7.8% in the first quarter, up from 6.0% in the first quarter of 2024
  • Cash flows from operating activities of $43 million, up $50 million from the first quarter of 2024
  • Returned $57.6 million to shareholders through $28.3 million in share repurchases and a quarterly dividend of $1.15 per share, aggregating $29.4 million in the first quarter
  • Refinanced long-term debt, extending most maturities, with issuance of $460 million of 3.000% convertible notes due 2030, repurchase of $368 million of 1.125% convertible notes due 2026, and refinancing of credit agreement with new $400 million term loan that matures in 2032 and $600 million revolving credit facility that matures in 2030
  • Strong liquidity position with $231 million of cash and cash equivalents and $595 million of availability on revolving credit facility at March 31, 2025
  • Completed the acquisition of Trans/Air, a provider of climate control systems for a wide range of buses and specialty vehicles, that has generated approximately $75 million in annual revenue in recent periods
  • In April 2025, completed the acquisition of Freedman Seating, a manufacturer of transportation seating solutions to the bus and specialty vehicle markets, that has generated approximately $125 million in annual revenue in recent periods

ELKHART, Ind.–(BUSINESS WIRE)–
LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today reported first quarter 2025 results.

“We delivered strong first quarter results, exceeding expectations despite ongoing macroeconomic headwinds. We continued to leverage both our innovative product portfolio and our distinct competitive advantages to capture content growth and market share across multiple product categories. This success, along with our steadfast focus on execution, effective cost management, and operational flexibility, enabled us to achieve both top and bottom line growth,” commented Jason Lippert, LCI Industries’ President and Chief Executive Officer. “Our first quarter results also demonstrated the agility of our operations, as we scaled production to support modest RV inventory rebuilding and drove 20% sales growth in our North American RV OEM business. We also recently acquired Freedman Seating and Trans/Air, deepening our position in the bus market, an adjacency shielded from consumer swings as city and transit fleet upgrades remain essential. Our ability to scale operations and presence in diverse end markets continues to support strong margin expansion, effectively driving an operating margin increase of 180 basis points.”

“This performance reinforces our confidence in the long-term potential of our approach. With an experienced leadership team that has successfully navigated a range of operating environments, we are taking proactive steps to deliver results now, not just when conditions improve,” Mr. Lippert continued. “We remain on track toward our $5 billion organic revenue goal in 2027. We are also on track to deliver an 85 basis point margin improvement in 2025 through optimizing infrastructure. As we move throughout the year, we will continue to effectively monitor, adjust, and lead through changing macroeconomic dynamics.”

“Our team’s unwavering commitment to operational excellence continues to drive LCI Industries forward, even as we navigate a complex macro environment,” commented Ryan Smith, LCI Industries’ Group President – North America. “Backed by a strong culture of innovation, quality, and service, we are executing with discipline across our operations and remain focused on delivering sustainable growth in 2025 and beyond. I wish to offer a sincere thank you for our teams who continue to perform and lead well in this tough environment!”

First Quarter 2025 Results

Consolidated net sales for the first quarter of 2025 were $1,045.6 million, an increase of 8% from 2024 first quarter net sales of $968.0 million. Net income in the first quarter of 2025 was $49.4 million, or $1.94 per diluted share, compared to $36.5 million, or $1.44 per diluted share, in the first quarter of 2024. Adjusted net income in the first quarter of 2025 was $55.6 million, or $2.19 per diluted share, excluding the loss on extinguishment of debt, net of tax effect, during the quarter, which was up 52% from net income in the first quarter of 2024. Adjusted EBITDA in the first quarter of 2025 was $110.9 million, compared to Adjusted EBITDA of $90.3 million in the first quarter of 2024. Additional information regarding adjusted net income and Adjusted EBITDA, as well as reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measure of net income, is provided in the “Supplementary Information – Reconciliation of Non-GAAP Measures” section below.

The increase in year-over-year net sales for the first quarter of 2025 was primarily driven by a $65.2 million increase in net sales of the OEM Segment compared to the same period of 2024.

April 2025 Results

April 2025 consolidated net sales were approximately $392 million, up 3% from April 2024, primarily due to increases in Adjacent Industries OEM sales of 8% and RV OEM sales of 7%, partially offset by a decrease in international sales of 13%.

OEM Segment – First Quarter Performance

OEM net sales for the first quarter of 2025 were $823.6 million, an increase of $65.2 million compared to the same period of 2024. RV OEM net sales for the first quarter of 2025 were $530.8 million, up 15% compared to the same prior year period, primarily driven by an 18% increase in North American travel trailer and fifth-wheel wholesale shipments and market share gains, partially offset by an 11% decrease in motorhome wholesale shipments. Adjacent Industries OEM net sales for the first quarter of 2025 were $292.8 million, down 2% year-over-year, primarily due to lower sales to North American marine and powersports OEMs, partially offset by higher sales to utility trailers OEMs. The lower sales were driven by current dealer inventory levels, inflation, and elevated interest rates impacting retail consumer demand.

Operating profit of the OEM Segment was $62.0 million in the first quarter of 2025, or 7.5% of net sales, compared to an operating profit of $32.8 million, or 4.3% of net sales, in the same period in 2024. The operating profit expansion of the OEM Segment for the quarter was primarily driven by the impact of fixed production overhead and SG&A costs spread over increased sales, decreases in material costs, and increases in production labor efficiencies, partially offset by decreases in selling prices.

Aftermarket Segment – First Quarter Performance

Aftermarket net sales for the first quarter of 2025 were $222.0 million, an increase of 6% compared to the same period of 2024. The increase was primarily driven by higher volumes within the RV and marine aftermarkets and market share gains in the automotive aftermarket. Operating profit of the Aftermarket Segment was $19.3 million in the first quarter of 2025, a decrease of $5.4 million compared to the same period of 2024. The operating profit margin of the Aftermarket Segment was 8.7% in the first quarter of 2025, compared to 11.8% in the same period in 2024, and was negatively impacted by increases in sales mix of lower margin products, decreases in automotive aftermarket production volume, and investments in capacity and distribution processes to support growth of the aftermarket segment.

“Our aftermarket business delivered strong results to start 2025, fueled by the success of recent innovations and the growing number of vehicles entering the repair and replacement cycle,” commented Jamie Schnur, LCI Industries’ Group President – Aftermarket. “Our long-term demand potential continues to expand as LCI Industries increases content on RVs, which increases the amount of components that will ultimately enter the repair and replacement cycle and require our support. To ensure we capitalize on this demand and other emerging opportunities, we remain focused on investing in dealer training programs and delivering exceptional service to strengthen our network relationships and enhance the customer experience.”

Income Taxes

The Company’s effective tax rate was 26.5% for the quarter ended March 31, 2025, compared to 24.3% for the quarter ended March 31, 2024. The increase in the effective tax rate was primarily due to discrete tax expense related to tax deficiencies on stock-based compensation and a decrease in cash surrender value of company owned life insurance policies.

Balance Sheet and Other Items

At March 31, 2025, the Company’s cash and cash equivalents balance was $231.2 million, compared to $165.8 million at December 31, 2024. The Company used $29.6 million for an acquisition, $29.4 million for dividend payments to shareholders, $28.3 million for share repurchases, and $9.0 million for capital expenditures in the three months ended March 31, 2025.

On March 14, 2025, the Company closed the sale of $460.0 million aggregate principal amount of 3.000% convertible senior notes due 2030 (“the 2030 Convertible Notes”) in a private placement to qualified institutional buyers, resulting in net proceeds to the Company of approximately $448.5 million after deducting the initial purchasers’ discounts. Concurrent with the issuance of the 2030 Convertible Notes, the Company entered into convertible note hedge transactions and warrant transactions. The proceeds from the sale of the 2030 Convertible Notes were used to repay $368.0 million face value of 1.125% convertible senior notes due 2026 (leaving $92 million of the 2026 notes outstanding), to enter into the convertible note hedge transactions for $67.6 million (which was partially offset by the proceeds from the warrant transactions of $27.6 million), to repurchase $28.3 million of common stock, and for general corporate purposes.

On March 25, 2025, the Company entered into a new credit agreement comprised of a $600.0 million revolving credit facility and a new $400.0 million term loan B. The proceeds from the term loan were used, in part, to repay the remaining outstanding principal of the term loan under the previous credit agreement of $280.0 million and the previous credit agreement was terminated.

Following the refinancing activities detailed above, long-term debt maturities previously due in 2026 are now extended to 2030 for the revolving credit facility and the 2030 Convertible Notes (other than $92 million of the 2026 notes that remain outstanding) and to 2032 for the term loan.

The Company’s outstanding long-term indebtedness, including current maturities, was $938.3 million at March 31, 2025, and the Company was in compliance with its debt covenants. As of March 31, 2025, the Company had $595.3 million of borrowing availability under the revolving credit facility.

Conference Call & Webcast

LCI Industries will host a conference call to discuss its first quarter results on Tuesday, May 6, 2025, at 8:30 a.m. Eastern time, which may be accessed by dialing (833) 470-1428 for participants in the U.S. and (929) 526-1599 for participants outside the U.S. using the required conference ID 255011. Due to the high volume of companies reporting earnings at this time, please be prepared for hold times of up to 15 minutes when dialing in to the call. In addition, an online, real-time webcast, as well as a supplemental earnings presentation, can be accessed on the Company’s website, www.investors.lci1.com.

A replay of the conference call will be available for two weeks by dialing (866) 813-9403 for participants in the U.S. and (44) 204-525-0658 for participants outside the U.S. and referencing access code 323974. A replay of the webcast will be available on the Company’s website immediately following the conclusion of the call.

About LCI Industries

LCI Industries (NYSE: LCII), through its Lippert subsidiary, is a global leader in supplying engineered components to the outdoor recreation and transportation markets. We believe our innovative culture, advanced manufacturing capabilities, and dedication to enhancing the customer experience have established Lippert as a reliable partner for both OEM and aftermarket customers. For more information, visit www.lippert.com.

Forward-Looking Statements

This press release contains certain “forward-looking statements” with respect to our financial condition, results of operations, profitability, margins, business strategies, operating efficiencies or synergies, competitive position, growth opportunities, acquisitions, plans and objectives of management, markets for the Company’s common stock, the impact of legal proceedings, and other matters. Statements in this press release that are not historical facts are “forward-looking statements” for the purpose of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, and involve a number of risks and uncertainties.

Forward-looking statements, including, without limitation, those relating to production levels, future business prospects, net sales, expenses and income (loss), operating margins, capital expenditures, tax rate, cash flow, financial condition, liquidity, covenant compliance, retail and wholesale demand, integration of acquisitions, R&D investments, commodity prices, addressable markets, and industry trends, whenever they occur in this press release are necessarily estimates reflecting the best judgment of the Company’s senior management at the time such statements were made. There are a number of factors, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those described in the forward-looking statements. These factors include, in addition to other matters described in this press release, the impacts of costs and availability of, and tariffs on, raw materials (particularly steel and aluminum) and other components, future pandemics, geopolitical tensions, armed conflicts, or natural disasters on the global economy and on the Company’s customers, suppliers, team members, business and cash flows, pricing pressures due to domestic and foreign competition, seasonality and cyclicality in the industries to which we sell our products, availability of credit for financing the retail and wholesale purchase of products for which we sell our components, inventory levels of retail dealers and manufacturers, availability of transportation for products for which we sell our components, the financial condition of our customers, the financial condition of retail dealers of products for which we sell our components, retention and concentration of significant customers, the costs, pace of and successful integration of acquisitions and other growth initiatives, availability and costs of production facilities and labor, team member benefits, team member retention, realization and impact of expansion plans, efficiency improvements and cost reductions, the disruption of business resulting from natural disasters or other unforeseen events, the successful entry into new markets, the costs of compliance with environmental laws, laws of foreign jurisdictions in which we operate, other operational and financial risks related to conducting business internationally, and increased governmental regulation and oversight, information technology performance and security, the ability to protect intellectual property, warranty and product liability claims or product recalls, interest rates, oil and gasoline prices, and availability, the impact of international, national and regional economic conditions and consumer confidence on the retail sale of products for which we sell our components, and other risks and uncertainties discussed more fully under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and in the Company’s subsequent filings with the Securities and Exchange Commission. Readers of this press release are cautioned not to place undue reliance on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. The Company disclaims any obligation or undertaking to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made, except as required by law.

 

LCI INDUSTRIES

OPERATING RESULTS

(unaudited)

 

 

Three Months Ended

March 31,

 

Last Twelve

Months

 

 

2025

 

 

 

2024

 

 

(In thousands, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

Net sales

$

1,045,590

 

$

968,029

 

$

3,818,769

Cost of sales

 

793,841

 

 

 

744,123

 

 

 

2,911,211

 

Gross profit

 

251,749

 

 

 

223,906

 

 

 

907,558

 

Selling, general and administrative expenses

 

170,432

 

 

 

166,295

 

 

 

665,615

 

Operating profit

 

81,317

 

 

 

57,611

 

 

 

241,943

 

Interest expense, net

 

5,991

 

 

 

9,321

 

 

 

25,569

 

Loss on extinguishment of debt

 

8,053

 

 

 

 

 

 

8,053

 

Income before income taxes

 

67,273

 

 

 

48,290

 

 

 

208,321

 

Provision for income taxes

 

17,835

 

 

 

11,745

 

 

 

52,561

 

Net income

$

49,438

 

 

$

36,545

 

 

$

155,760

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

Basic

$

1.94

 

 

$

1.44

 

 

$

6.12

 

Diluted

$

1.94

 

 

$

1.44

 

 

$

6.10

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

Basic

 

25,426

 

 

 

25,374

 

 

 

25,461

 

Diluted

 

25,426

 

 

 

25,389

 

 

 

25,518

 

 

 

 

 

 

 

Depreciation

$

16,663

 

 

$

18,585

 

 

$

68,471

 

Amortization

$

12,879

 

 

$

14,104

 

 

$

54,075

 

Capital expenditures

$

9,038

 

 

$

8,608

 

 

$

42,763

 

 

LCI INDUSTRIES

SEGMENT RESULTS

(unaudited)

 

 

Three Months Ended

March 31,

 

Last Twelve

Months

 

 

2025

 

 

 

2024

 

 

(In thousands)

 

 

 

 

 

Net sales:

 

 

 

 

 

OEM Segment:

 

 

 

 

 

RV OEMs:

 

 

 

 

 

Travel trailers and fifth-wheels

$

471,194

 

$

390,763

 

$

1,595,009

Motorhomes

 

59,608

 

 

 

68,838

 

 

 

223,836

 

Adjacent Industries OEMs

 

292,753

 

 

 

298,710

 

 

 

1,106,849

 

Total OEM Segment net sales

 

823,555

 

 

 

758,311

 

 

 

2,925,694

 

Aftermarket Segment:

 

 

 

 

 

Total Aftermarket Segment net sales

 

222,035

 

 

 

209,718

 

 

 

893,075

 

Total net sales

$

1,045,590

 

 

$

968,029

 

 

$

3,818,769

 

 

 

 

 

 

 

Operating profit:

 

 

 

 

 

OEM Segment

$

61,974

 

 

$

32,836

 

 

$

136,219

 

Aftermarket Segment

 

19,343

 

 

 

24,775

 

 

 

105,724

 

Total operating profit

$

81,317

 

 

$

57,611

 

 

$

241,943

 

 

 

 

 

 

 

Depreciation and amortization:

 

 

 

 

 

OEM Segment depreciation

$

12,327

 

 

$

14,035

 

 

$

51,776

 

Aftermarket Segment depreciation

 

4,336

 

 

 

4,550

 

 

 

16,695

 

Total depreciation

$

16,663

 

 

$

18,585

 

 

$

68,471

 

 

 

 

 

 

 

OEM Segment amortization

$

9,114

 

 

$

10,280

 

 

$

38,677

 

Aftermarket Segment amortization

 

3,765

 

 

 

3,824

 

 

 

15,398

 

Total amortization

$

12,879

 

 

$

14,104

 

 

$

54,075

 

 

LCI INDUSTRIES

BALANCE SHEET INFORMATION

(unaudited)

 

 

March 31,

 

December 31,

 

 

2025

 

 

 

2024

 

(In thousands)

 

 

 

 

 

 

 

ASSETS

 

 

 

Current assets

 

 

 

Cash and cash equivalents

$

231,243

 

$

165,756

Accounts receivable, net

 

357,138

 

 

 

199,560

 

Inventories, net

 

717,438

 

 

 

736,604

 

Prepaid expenses and other current assets

 

61,269

 

 

 

58,318

 

Total current assets

 

1,367,088

 

 

 

1,160,238

 

Fixed assets, net

 

428,046

 

 

 

432,728

 

Goodwill

 

590,204

 

 

 

585,773

 

Other intangible assets, net

 

393,555

 

 

 

392,018

 

Operating lease right-of-use assets

 

222,841

 

 

 

224,313

 

Other long-term assets

 

98,264

 

 

 

99,669

 

Total assets

$

3,099,998

 

 

$

2,894,739

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities

 

 

 

Current maturities of long-term indebtedness

$

3,646

 

 

$

423

 

Accounts payable, trade

 

220,768

 

 

 

187,684

 

Current portion of operating lease obligations

 

37,543

 

 

 

38,671

 

Accrued expenses and other current liabilities

 

199,310

 

 

 

185,275

 

Total current liabilities

 

461,267

 

 

 

412,053

 

Long-term indebtedness

 

934,632

 

 

 

756,830

 

Operating lease obligations

 

199,766

 

 

 

199,929

 

Deferred taxes

 

17,716

 

 

 

26,110

 

Other long-term liabilities

 

119,904

 

 

 

112,931

 

Total liabilities

 

1,733,285

 

 

 

1,507,853

 

Total stockholders’ equity

 

1,366,713

 

 

 

1,386,886

 

Total liabilities and stockholders’ equity

$

3,099,998

 

 

$

2,894,739

 

 

LCI INDUSTRIES

SUMMARY OF CASH FLOWS

(unaudited)

 

 

Three Months Ended

March 31,

 

 

2025

 

 

 

2024

 

(In thousands)

 

 

 

Cash flows from operating activities:

 

 

 

Net income

$

49,438

 

 

$

36,545

 

Adjustments to reconcile net income to cash flows provided by (used in) operating activities:

 

 

 

Depreciation and amortization

 

29,542

 

 

 

32,689

 

Stock-based compensation expense

 

4,933

 

 

 

4,327

 

Loss on extinguishment of debt

 

8,053

 

 

 

 

Other non-cash items

 

2,181

 

 

 

1,107

 

Changes in assets and liabilities, net of acquisitions of businesses:

 

 

 

Accounts receivable, net

 

(149,644

)

 

 

(131,059

)

Inventories, net

 

39,121

 

 

 

32,892

 

Prepaid expenses and other assets

 

5,800

 

 

 

(2,392

)

Accounts payable, trade

 

30,005

 

 

 

12,038

 

Accrued expenses and other liabilities

 

23,289

 

 

 

6,199

 

Net cash flows provided by (used in) operating activities

 

42,718

 

 

 

(7,654

)

Cash flows from investing activities:

 

 

 

Capital expenditures

 

(9,038

)

 

 

(8,608

)

Acquisition of business

 

(29,579

)

 

 

 

Other investing activities

 

(3,423

)

 

 

173

 

Net cash flows used in investing activities

 

(42,040

)

 

 

(8,435

)

Cash flows from financing activities:

 

 

 

Vesting of stock-based awards, net of shares tendered for payment of taxes

 

(4,813

)

 

 

(9,040

)

Proceeds from revolving credit facility

 

 

 

 

86,248

 

Repayments under revolving credit facility

 

(19,261

)

 

 

(76,927

)

Proceeds from term loan borrowings

 

391,000

 

 

 

 

Repayments under term loan and other borrowings

 

(280,093

)

 

 

(5

)

Proceeds from issuance of convertible notes

 

448,500

 

 

 

 

Repurchase of convertible notes

 

(368,920

)

 

 

 

Purchases of convertible note hedge contracts

 

(67,574

)

 

 

 

Proceeds from issuance of warrants concurrent with note hedge contracts

 

27,600

 

 

 

 

Partial unwind of convertible note hedge and warrants

 

1,378

 

 

 

 

Payment of debt issuance costs

 

(3,122

)

 

 

 

Payment of dividends

 

(29,352

)

 

 

(26,721

)

Repurchases of common stock

 

(28,255

)

 

 

 

Other financing activities

 

(217

)

 

 

(2

)

Net cash flows provided by (used in) financing activities

 

66,871

 

 

 

(26,447

)

Effect of exchange rate changes on cash and cash equivalents

 

(2,062

)

 

 

(996

)

Net increase (decrease) in cash and cash equivalents

 

65,487

 

 

 

(43,532

)

Cash and cash equivalents at beginning of period

 

165,756

 

 

 

66,157

 

Cash and cash equivalents at end of period

$

231,243

 

 

$

22,625

 

 

LCI INDUSTRIES

SUPPLEMENTARY INFORMATION

(unaudited)

 

 

Three Months Ended

 

Last Twelve

Months

 

 

March 31,

 

 

 

2025

 

2024

 

 

Industry Data(1)(in thousands of units):

 

 

 

 

 

 

Industry Wholesale Production:

 

 

 

 

 

 

Travel trailer and fifth-wheel RVs

 

86.4

 

 

73.5

 

 

304.5

 

Motorhome RVs

 

9.3

 

 

10.4

 

 

33.8

 

Industry Retail Sales:

 

 

 

 

 

 

Travel trailer and fifth-wheel RVs

 

60.6

(2)

 

65.4

 

 

302.7

(2)

Impact on dealer inventories

 

25.8

(2)

 

8.1

 

 

1.8

(2)

Motorhome RVs

 

9.3

(2)

 

9.8

 

 

39.5

(2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Twelve Months Ended

 

 

 

 

March 31,

 

 

 

 

2025

 

2024

 

 

 

Lippert Content Per Industry Unit Produced:

 

 

 

 

 

 

Travel trailer and fifth-wheel RV

$

5,164

 

$

5,097

 

 

 

Motorhome RV

$

3,750

 

$

3,656

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

2025

 

2024

 

2024

 

Balance Sheet Data (debt availability in millions):

 

 

 

 

 

 

Remaining availability under the revolving credit facility (3)

$

595.3

 

$

153.8

 

$

452.5

 

Days sales in accounts receivable, based on last twelve months

 

29.2

 

 

30.5

 

 

29.9

 

Inventory turns, based on last twelve months

 

4.1

 

 

3.7

 

 

4.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2025

 

 

 

Estimated Full Year Data:

 

 

 

 

 

 

Capital expenditures

$50 – $70 million

 

 

 

Depreciation and amortization

$115 – $125 million

 

 

 

Stock-based compensation expense

$18 – $23 million

 

 

 

Annual tax rate

25% – 27%

 

 

 

 

 

 

 

 

 

 

(1)

Industry wholesale production data for travel trailer and fifth-wheel RVs and motorhome RVs provided by the Recreation Vehicle Industry Association. Industry retail sales data provided by Statistical Surveys, Inc.

(2)

March 2025 retail sales data for RVs has not been published yet, therefore 2025 retail data for RVs includes an estimate for March 2025 retail units. Retail sales data will likely be revised upwards in future months as various states report.

(3)

Remaining availability under the revolving credit facility is subject to covenant restrictions.

LCI INDUSTRIES

SUPPLEMENTARY INFORMATION

RECONCILIATION OF NON-GAAP MEASURES

(unaudited)

 

The following table reconciles net income to Adjusted EBITDA and net income as a percentage of net sales to Adjusted EBITDA as a percentage of net sales.

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

(In thousands)

 

 

 

Net income

$

49,438

 

 

$

36,545

 

Interest expense, net

 

5,991

 

 

 

9,321

 

Provision for income taxes

 

17,835

 

 

 

11,745

 

Depreciation expense

 

16,663

 

 

 

18,585

 

Amortization expense

 

12,879

 

 

 

14,104

 

EBITDA

$

102,806

 

 

$

90,300

 

Loss on extinguishment of debt

$

8,053

 

 

$

 

Adjusted EBITDA

$

110,859

 

 

$

90,300

 

 

 

 

 

Net sales

$

1,045,590

 

 

$

968,029

 

Net income as a percentage of net sales

 

4.7

%

 

 

3.8

%

Adjusted EBITDA as a percentage of net sales

 

10.6

%

 

 

9.3

%

The following table reconciles net income to adjusted net income and net income per diluted share to adjusted net income per diluted share.

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

(In thousands, except per share amounts)

 

 

 

Net income

$

49,438

 

 

$

36,545

Loss on extinguishment of debt

 

8,053

 

 

 

Tax effect of adjustment

 

(1,930

)

 

 

Adjusted net income

$

55,561

 

 

$

36,545

 

 

 

 

Net income per common share – diluted

$

1.94

 

 

$

1.44

Loss on extinguishment of debt

 

0.32

 

 

$

Tax effect of adjustment

 

(0.07

)

 

$

Adjusted net income per common share – diluted

$

2.19

 

 

$

1.44

 

 

 

 

Weighted average common shares outstanding – diluted

 

25,426

 

 

 

25,389

In addition to reporting financial results in accordance with U.S. GAAP, the Company has provided the non-GAAP performance measures of Adjusted EBITDA, Adjusted EBITDA as a percentage of net sales, adjusted net income, and adjusted net income per diluted common share to illustrate and improve comparability of its results from period to period. Adjusted EBITDA is defined as net income before interest expense, net, provision for income taxes, depreciation expense, amortization expense, and loss on extinguishment of debt during the three-month periods ended March 31, 2025 and 2024. Adjusted net income is defined as net income adjusted for loss on extinguishment of debt and the related tax effect during the three-month period ended March 31, 2025. The Company considers these non-GAAP measures in evaluating and managing the Company’s operations and believes that discussion of results adjusted for these items is meaningful to investors because it provides a useful analysis of ongoing underlying operating trends. These measures are not in accordance with, nor are they substitutes for, GAAP measures, and they may not be comparable to similarly titled measures used by other companies.

 

Lillian D. Etzkorn, CFO

Phone: (574) 535-1125

E Mail: [email protected]

KEYWORDS: United States North America Indiana

INDUSTRY KEYWORDS: Retail Automotive Manufacturing Manufacturing Transportation Recreational Vehicles Travel Sports Aftermarket Outdoors Specialty Other Manufacturing Machinery Automotive Machine Tools, Metalworking & Metallurgy Engineering

MEDIA:

Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2025

–  Quarterly Revenue of $80.4 million  –

–  Gross Margin of 35.0%  –

–  Net Loss of $(0.3) million  –

–  Adjusted EBITDA1 of $12.8 million  –

–  Backlog and Awarded Orders Increased 5% Year-Over-Year to $645.1 million  –

–  Provides Second Quarter and Full Year 2025 Outlook  –

PORTLAND, Tenn., May 06, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system (“EBOS”) solutions and components, including battery energy storage solutions (“BESS”) and Original Equipment Manufacturer (“OEM”) components for the global energy transition market, today announced results for its first quarter ended March 31, 2025.

“We began the year with a strong start, delivering revenue above our guided range. The investment that we have made in our commercial function is paying dividends as evidenced in both the growth and quality of our order book. I’m proud of the robust backlog and awarded orders of $645 million, with approximately $500 million scheduled for the coming four quarters. The strategic initiatives that are driving increased market penetration and diversification are progressing very well, with commercial success in international, CC&I, BESS, and OEM markets,” said Brandon Moss, CEO of Shoals.

“While volatility and uncertainty may dominate today’s headlines, the markets that we operate within are showing continued strength. Our value proposition of delivering high-quality, innovative products combined with exceptional engineering and design support is resonating with new and existing customers. The underlying fundamentals of both our industry and business opportunities remain very positive. Projects are moving forward, and 2025 is shaping up to be a solid year,” added Mr. Moss.

________________________
1 Non-GAAP financial measures referenced in this release are used by management to assist investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Reconciliations of non-GAAP operating measures to the most directly comparable GAAP financial measures are included in the non-GAAP reconciliation in this release. Non-GAAP measures should not be used as a substitute for the closest comparable GAAP measures.



First

Quarter 2025 Financial Results

Revenue decreased 11.5%, to $80.4 million, compared to $90.8 million for the prior-year period, driven by strategic pricing actions, volume discounts, and customer and product mix.

Gross profit was $28.1 million, compared to $36.5 million in the prior-year period. Gross profit as a percentage of revenue was 35.0% compared to 40.2% in the prior-year period. The decline from the prior-year period was driven by strategic pricing actions, volume discounts, customer and product mix, and reduced fixed cost absorption due to lower revenues.

General and administrative expenses were $21.7 million, compared to $22.8 million during the same period in the prior year. The decrease in general and administrative expenses was the result of a $3.3 million decrease in general legal expenses for intellectual property and shareholder litigation matters, offset by a $1.7 million increase in legal expenses related to wire insulation shrinkback litigation.

Income from operations was $4.3 million, compared to $11.6 million during the prior-year period.

Net income (loss) was $(0.3) million compared to $4.8 million during the prior-year period. Earnings (loss) per share was $(0.00) compared to $0.03 in the prior-year period.

Adjusted EBITDA1 decreased $7.7 million to $12.8 million compared to $20.5 million for the prior-year period.

Adjusted net income1 decreased $7.4 million to $5.2 million compared to $12.6 million during the prior-year period. Adjusted diluted earnings per share1 were $0.03 compared to $0.07 in the prior-year period.

Backlog and Awarded Orders

The Company’s backlog and awarded orders as of March 31, 2025, were $645.1 million, representing a 4.9% increase compared to the prior-year period and a 1.6% sequential increase from December 31, 2024. The increase in backlog and awarded orders as compared to the prior-year period reflects consistent demand for the Company’s innovative products, with growth in international markets, which comprises more than 13.4% of backlog and awarded orders.  

Backlog represents signed purchase orders or contractual minimum purchase commitments with take-or-pay provisions and awarded orders are orders we are in the process of documenting with a contract but for which a contract has not yet been signed.

Second Quarter 2025 Outlook

The Company is providing an outlook for the second quarter given the near-term uncertainty in the utility scale solar market, which has resulted in shifting order patterns. Based on current business conditions, business trends and other factors, for the quarter ending June 30, 2025, the Company expects:

  • Revenue in the range of $100 million to $110 million
  • Adjusted EBITDA1 in the range of $20 million to $25 million

Full Year 2025 Outlook

Based on current business conditions, business trends and other factors, for the full year 2025, the Company expects:

  • Revenue in the range of $410 million to $450 million
  • Adjusted EBITDA1 in the range of $100 million to $115 million
  • Cash Flow from operations in the range of $30 million to $45 million
  • Capital expenditures in the range of $25 million to $35 million
  • Interest expense in the range of $8 million to $12 million

A reconciliation of Adjusted EBITDA1 guidance, which is a forward-looking measure that is a non-GAAP measure, to the most closely comparable GAAP measure is not provided because we are unable to provide such reconciliation without unreasonable effort. The inability to provide a quantitative reconciliation is due to the uncertainty and inherent difficulty in predicting the occurrence, the financial impact and the periods in which the components of the applicable GAAP measures and non-GAAP adjustments may be recognized. The GAAP measure may include the impact of such items as non-cash share-based compensation, amortization of intangible assets and the tax effect of such items, in addition to other items we have historically excluded from Adjusted EBITDA. We expect to continue to exclude these items in future disclosures of this non-GAAP measure and may also exclude other similar items that may arise in the future.

Webcast and Conference Call Information

Company management will host a webcast and conference call on May 6, 2025, at 8:00 a.m. Eastern Time, to discuss the Company’s financial results.

Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company’s website at https://investors.shoals.com.

About Shoals Technologies Group, Inc.

Shoals Technologies Group, Inc. is a leading provider of electrical balance of system (“EBOS”) solutions and components, including battery energy storage solutions (“BESS”) and Original Equipment Manufacturer (“OEM”) components, for the global energy transition market. Since its founding in 1996, the Company has introduced innovative technologies and systems solutions that allow its customers to substantially increase installation efficiency and safety while improving system performance and reliability. Shoals Technologies Group, Inc. is a recognized leader in the renewable energy industry whose solutions are deployed on over 70 GW of solar systems globally. For additional information, please visit: https://www.shoals.com.

Investor Relations Contact

Shoals Technologies Group, Inc.
Email: [email protected]

Forward-Looking Statements
This report contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our possible or assumed future results of operations; expectations regarding the utility-scale solar market; project delays; regulatory environment; the effects of strategic pricing actions, volume discounts and customer mix in our key markets; pipeline and orders; business strategies, plans and expectations, including sales and marketing goals; technology developments; financing and investment plans; warranty and liability accruals and estimates of loss or gains; estimates of potential loss related to the wire insulation shrinkback matter (as defined below); litigation strategy and expected benefits or results from the current intellectual property and wire insulation shrinkback litigation; potential growth opportunities, including opportunities associated with our entry into new markets; production and capacity at our plants; and potential repurchases under the Company’s Repurchase Program (as defined below). Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would” or similar expressions and the negatives of those terms.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Some of the key factors and scenarios that could cause actual results to differ from our expectations include, among others, If demand for solar energy projects diminishes, we may not be able to grow; if we fail to accurately estimate the potential losses related to the wire insulation shrinkback matter, or fail to recover the costs and expenses incurred by us from the supplier; the interruption of the flow of raw materials from international vendors has disrupted our supply chain, including as a result of the imposition of additional duties, tariffs, and other charges on imports and exports; the imposition of trade restrictions, import tariffs, anti-dumping, and countervailing duties; we have modified, and in the future may modify, our business strategy to abandon lines of business or implement new lines of business, and modifying our business strategy could have an adverse effect on our business and financial results; amounts included in our backlog and awarded orders may not result in actual revenue or translate into profits; defects or performance problems in our products or their parts, whether due to manufacturing, installation, or use, including those related to the wire insulation shrinkback matter, have a high consequence of failure and can lead to equipment and systems failure, physical injury or death; we have experienced, and may experience in the future, delays, disruptions, quality control, or reputational problems in our manufacturing operations in part due to our vendor concentration; if we fail to retain our key personnel and attract additional qualified personnel; our products are primarily manufactured and shipped from our production facilities in Tennessee, and any damage or disruption at these facilities may harm our business; we may face difficulties with respect to the planned consolidation and relocation of our Tennessee-based manufacturing and distribution operations, and may not realize the benefits thereof; safety issues may subject us to penalties, negatively impact customer relationships, result in higher operating costs, and negatively impact employee morale and turnover; the market for our products is competitive, and we face increased competition as new and existing competitors introduce EBOS system solutions and components; macroeconomic conditions, including high inflation, high interest rates, and geopolitical instability, impact our business and financial results; we are subject to risks associated with the patent infringement complaints that we filed with the U.S. International Trade Commission (“ITC”) and District Courts; if we fail to, or incur significant costs in order to obtain, maintain, protect, defend, or enforce our intellectual property portfolio and other proprietary rights, including the patents we are asserting in ongoing patent infringement litigation; acquisitions, joint ventures, and/or investments and the failure to integrate acquired businesses could disrupt our business; a loss of one or more of our significant customers, their inability to perform under their contracts, or their default in payment could harm our business; a significant drop in the price of electricity may harm our business; the unauthorized access to our information technology systems or the disclosure of personal or sensitive data or confidential information, whether through a breach of our computer system or otherwise, could severely disrupt our business; failure of our information technology systems, including those managed by third parties, whether intentional or inadvertent, could lead to delays in our business operations and, if significant or extreme, affect our results of operations; our expansion outside the U.S. could subject us to additional business, financial, regulatory, and competitive risks; our indebtedness could adversely affect our financial flexibility, restrict our current and future operations, and our competitive position; existing electric utility industry, federal, state, and municipal renewable energy and solar energy policies and regulations, including zoning and siting laws, and any subsequent changes, present technical, regulatory, and economic barriers to the purchase and use of solar energy systems that may significantly reduce demand for our products or harm our ability to compete; changes in tax laws or regulations that are applied adversely to us, or our customers could materially adversely affect our business, financial condition, results of operations, and prospects; and the market price of our Class A common stock may decline and may continue to be subject to significant volatility.

These and other important risk factors are described more fully in the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and other documents filed with the Securities and Exchange Commission and could cause actual results to vary from expectations. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this report. You should read this report with the understanding that our actual future results may be materially different from what we expect.

Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Non-GAAP Financial Measures


Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted Earnings per Share (“EPS”)

We define Adjusted Gross Profit as gross profit plus wire insulation shrinkback expenses. We define Adjusted Gross Profit Percentage as Adjusted Gross Profit divided by revenue. We define Adjusted EBITDA as net income (loss) plus/(minus) (i) interest expense, (ii) interest income, (iii) income tax expense, (iv) depreciation expense, (v) amortization of intangibles, (vi) equity-based compensation, (vii) wire insulation shrinkback expenses, and (viii) wire insulation shrinkback litigation expenses. We define Adjusted Net Income as net income (loss) plus (i) amortization of intangibles, (ii) amortization / write-off of deferred financing costs, (iii) equity-based compensation, (iv) wire insulation shrinkback expenses, and (v) wire insulation shrinkback litigation expenses, all net of applicable income taxes. We define Adjusted Diluted EPS as Adjusted Net Income divided by the diluted weighted average shares of Class A common stock outstanding for the applicable period.

Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS are intended as supplemental measures of performance that are neither required by, nor presented in accordance with, GAAP. We present Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS because we believe they assist investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS: (i) as factors in evaluating management’s performance when determining incentive compensation, as applicable; (ii) to evaluate the effectiveness of our business strategies; and (iii) because our credit agreement uses measures similar to Adjusted EBITDA, Adjusted Net Income and Adjusted Diluted EPS to measure our compliance with certain covenants.

Among other limitations, Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments; do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations; and may be calculated by other companies in our industry differently than we do or not at all, which may limit their usefulness as comparative measures.

Because of these limitations, Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP. You should review the reconciliation of gross profit to Adjusted Gross Profit and Adjusted Gross Profit Percentage, net income (loss) to Adjusted EBITDA, and net income (loss) to Adjusted Net Income and Adjusted Diluted EPS below and not rely on any single financial measure to evaluate our business.

 
Shoals Technologies Group, Inc.

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands, except shares and par value)
 
  March 31,

2025
  December 31,
2024
Assets      
Current Assets      
Cash and cash equivalents $ 35,609     $ 23,511  
Accounts receivable, net   67,704       78,181  
Unbilled receivables   10,409       20,834  
Inventory, net   61,173       55,977  
Other current assets   12,851       9,849  
Total Current Assets   187,746       188,352  
Property, plant and equipment, net   30,040       28,222  
Goodwill   69,941       69,941  
Other intangible assets, net   39,187       41,083  
Deferred tax assets   451,872       454,160  
Other assets   9,635       11,322  
Total Assets $ 788,421     $ 793,080  
       
Liabilities and Stockholders’ Equity      
Current Liabilities      
Accounts payable $ 26,714     $ 20,032  
Accrued expenses and other   12,418       12,541  
Warranty liability—current portion   25,956       29,602  
Deferred revenue   15,195       18,737  
Total Current Liabilities   80,283       80,912  
Revolving line of credit   141,750       141,750  
Warranty liability, less current portion   5,457       11,392  
Other long-term liabilities   2,003       2,226  
Total Liabilities   229,493       236,280  
Commitments and Contingencies      
Stockholders’ Equity      
Preferred stock, $0.00001 par value – 5,000,000 shares authorized; none issued and outstanding as of March 31, 2025 and December 31, 2024          
Class A common stock, $0.00001 par value – 1,000,000,000 shares authorized; 171,078,789 and 170,670,779 shares issued; 167,170,402 and 166,762,392 outstanding as of March 31, 2025 and December 31, 2024, respectively   2       2  
Additional paid-in capital   485,960       483,550  
Treasury stock, at cost, 3,908,387 shares as of March 31, 2025 and December 31, 2024, respectively   (25,331 )     (25,331 )
Retained earnings   98,297       98,579  
Total stockholders’ equity   558,928       556,800  
Total Liabilities and Stockholders’ Equity $ 788,421     $ 793,080  

 
Shoals Technologies Group, Inc.

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands, except per share amounts)
 
  Three Months Ended March 31,
    2025       2024  
Revenue $ 80,631     $ 90,807  
Cost of revenue   52,221       54,347  
Gross profit   28,140       36,460  
Operating expenses      
General and administrative expenses   21,693       22,772  
Depreciation and amortization   2,135       2,104  
Total operating expenses   23,828       24,876  
Income from operations   4,312       11,584  
Interest expense   (2,415 )     (4,475 )
Interest income   118       113  
Income before income taxes   2,015       7,222  
Income tax expense   (2,297 )     (2,448 )
Net income (loss) $ (282 )   $ 4,774  
       
Earnings (loss) per share of Class A common stock:      
Basic $ (0.00 )   $ 0.03  
Diluted $ (0.00 )   $ 0.03  
Weighted average shares of Class A common stock outstanding:      
Basic   166,960       170,282  
Diluted   166,960       170,514  
       

Shoals Technologies Group, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands)
 
  Three Months Ended March 31,
    2025       2024  
Cash Flows from Operating Activities      
Net income (loss) $ (282 )   $ 4,774  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization   3,287       3,002  
Amortization/write off of deferred financing costs   156       2,626  
Equity-based compensation   2,661       5,023  
Provision for obsolete or slow-moving inventory   252        
Provision for warranty expense   257       565  
Deferred taxes   2,288       2,495  
Changes in assets and liabilities:      
Accounts receivable   10,477       3,715  
Unbilled receivables   10,425       16,730  
Inventory   (5,448 )     (6,761 )
Other assets   (1,471 )     (3,165 )
Accounts payable   6,682       1,332  
Accrued expenses and other   (347 )     (13,402 )
Warranty liability   (9,837 )     (3,680 )
Deferred revenue   (3,542 )     (394 )
Net Cash Provided by Operating Activities   15,558       12,860  
Cash Flows from Investing Activities      
Purchases of property, plant and equipment   (3,209 )     (2,483 )
Net Cash Used in Investing Activities   (3,209 )     (2,483 )
Cash Flows from Financing Activities      
Employee withholding taxes related to net settled equity awards   (251 )     (816 )
Payments on term loan facility         (143,750 )
Proceeds from revolving credit facility   20,000       143,750  
Repayments of revolving credit facility   (20,000 )     (15,000 )
Deferred financing costs         (2,032 )
Net Cash Used in Financing Activities   (251 )     (17,848 )
Net Increase (Decrease) in Cash and Cash Equivalents   12,098       (7,471 )
Cash and Cash Equivalents—Beginning of Period   23,511       22,707  
Cash and Cash Equivalents—End of Period $ 35,609     $ 15,236  



Shoals Technologies Group, Inc.


Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income and

Adjusted Diluted Earnings per Share (“EPS”) (Unaudited)

Reconciliation of Gross Profit to Adjusted Gross Profit and Adjusted Gross Profit Percentage (in thousands):

  Three Months Ended March 31,
    2025       2024  
Revenue $ 80,361     $ 90,807  
Cost of revenue   52,221       54,347  
Gross profit $ 28,140     $ 36,460  
Gross profit percentage   35.0 %     40.2 %
       
Wire insulation shrinkback expenses (a) $     $  
Adjusted gross profit $ 28,140     $ 36,460  
Adjusted gross profit percentage   35.0 %     40.2 %


Reconciliation of Net Income (Loss) to Adjusted EBITDA (in thousands):

  Three Months Ended March 31,
    2025       2024  
Net income (loss) $ (282 )   $ 4,774  
Interest expense   2,415       4,475  
Interest income   (118 )     (113 )
Income tax expense   2,297       2,448  
Depreciation expense   1,391       1,106  
Amortization of intangibles   1,896       1,896  
Equity-based compensation   2,661       5,023  
Wire insulation shrinkback expenses(a)          
Wire insulation shrinkback litigation expenses (b)   2,529       849  
Adjusted EBITDA $ 12,789     $ 20,458  


Reconciliation of Net Income (Loss) to Adjusted Net Income (in thousands):

  Three Months Ended March 31,
    2025       2024  
Net income (loss) $ (282 )   $ 4,774  
Amortization of intangibles   1,896       1,896  
Amortization / write-off of deferred financing costs   156       2,626  
Equity-based compensation   2,661       5,023  
Wire insulation shrinkback expenses(a)          
Wire insulation shrinkback litigation expenses (b)   2,529       849  
Tax impact of adjustments (c)   (1,767 )     (2,547 )
Adjusted Net Income $ 5,193     $ 12,621  



(a)
  For the three months ended March 31, 2025 and 2024, there were no expenses related to warranty for wire insulation shrinkback relating to the identification, repair and replacement of a subset of wire harnesses presenting unacceptable levels of wire insulation shrinkback. We consider expenses incurred in connection with the identification, repair and replacement of the impacted wire harnesses distinct from normal, ongoing service identification, repair and replacement expenses that would be reflected under ongoing warranty expenses within the operation of our business, which we do not exclude from our non-GAAP measures. In the future, we also intend to exclude from our non-GAAP measures the benefit of liability releases, if any. We believe excluding expenses from these discrete liability events provides investors with a better view of the operating performance of our business and allows for comparability through periods.

(b)  For the three months ended March 31, 2025 and 2024, represents $2.5 million and $0.8 million, respectively, of expenses incurred in connection with the lawsuit initiated by the Company against the supplier of the defective wire. We consider this litigation distinct from ordinary course legal matters given the expected magnitude of the expenses, the nature of the allegations in the Company’s complaint, the amount of damages sought, and the impact of the matter underlying the litigation on the Company’s financial results. In the future, we also intend to exclude from our non-GAAP measures the benefit of recovery, if any. We believe excluding expenses from these discrete litigation events provides investors with a better view of the operating performance of our business and allows for comparability through periods.

(c)  Shoals Technologies Group, Inc. is subject to U.S. Federal income taxes, in addition to state and local taxes. Represents the estimated tax impact of all Adjusted Net Income add-backs, excluding those which represent permanent differences between book versus tax. The adjustment to the provision for income tax reflects the effective tax rates below.

  Three Months Ended March 31,
  2025   2024
Statutory U.S. Federal income tax rate 21.0 %   21.0 %
Permanent adjustments 0.6 %   0.8 %
State and local taxes (net of federal benefit) 2.8 %   2.7 %
Effective income tax rate for Adjusted Net Income 24.4 %   24.5 %


Reconciliation of Diluted Weighted Average Shares Outstanding to Adjusted Diluted Weighted Average Shares Outstanding (in thousands, except per share):

  Three Months Ended March 31,
    2025       2024  
Adjusted diluted weighted average shares outstanding   166,960       170,514  
       
Adjusted Net Income $ 5,193     $ 12,621  
Adjusted Diluted EPS $ 0.03     $ 0.07  



ADM Reports First Quarter 2025 Results, Affirms Full-Year EPS Guidance

ADM Reports First Quarter 2025 Results, Affirms Full-Year EPS Guidance

Reported EPS2 of $0.61, Adjusted EPS1,2 of $0.70

CHICAGO–(BUSINESS WIRE)–
ADM (NYSE: ADM) today reported financial results for the first quarter ended March 31, 2025.

First Quarter 2025 Highlights

  • Net earnings of $295 million, adjusted net earnings1 of $338 million
  • Earnings per share2 of $0.61, with adjusted EPS1,2 of $0.70, both down versus the prior year quarter
  • Trailing four-quarter average return on invested capital (ROIC) of 5.4%, trailing four-quarter average adjusted ROIC1 of 7.0%
  • Cash flows used in operating activities were $(342) million, with cash flows from operations before working capital1,3 of $439 million

“ADM delivered results aligned with our outlook and the market expectations for the first quarter. In a challenging and uncertain external environment, we advanced multiple aspects of our self-help agenda, including delivering operational improvements in North America, driving cost savings through targeted operational and organizational realignments, advancing our pipeline of portfolio simplification opportunities, and continuing our disciplined approach to capital allocation,” said Chair of the Board and CEO Juan Luciano.

“In AS&O, we are leveraging our global footprint and taking actions to drive operational improvement and targeted network consolidation to balance a challenging environment. In Carb Solutions, we continue to achieve solid operational results, aligned with our expectations. In Nutrition, we see green shoots with improved operating profit performance.

“Looking forward, the focused execution of our team will be foundational to navigating market uncertainty. Based on our self-help agenda and execution agility, we are reaffirming our full-year guidance for 2025, but expect to deliver at the lower end of the range, given current market conditions.”

_______________________________

1

Non-GAAP financial measures; see pages 6-7 and 13-16 for explanations and reconciliations.

2

All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis.

3

Cash flows from operations before working capital is a Non-GAAP financial measure and is cash flows used in operating activities of $(342) million, adjusted for changes in operating assets and liabilities of $(781) million for the first quarter of 2025.

 
 

First Quarter 2025 Results 

 

1Q 2025 Results Overview

($ in millions except per share amounts)

 

 

GAAP Measures

 

 

Earnings Before

Income Taxes

 

EPS2 (as reported)

1Q 2025

 

$353

 

$0.61

Percent change vs. 1Q 2024

 

(60)%

 

(57)%

 

 

 

Non-GAAP Measures

 

 

Total Segment

Operating Profit1

 

Adjusted EPS1,2

1Q 2025

 

$747

 

$0.70

Percent change vs. 1Q 2024

 

(38)%

 

(52)%

 

Summary of First Quarter 2025

For the first quarter ended March 31, 2025, earnings before income taxes were $353 million, down 60% versus the prior year quarter. Earnings per share2 on a GAAP basis were $0.61, down 57% from the prior year quarter, and adjusted earnings per share1,2 were $0.70, down 52% versus the prior year quarter. Total segment operating profit1 was $747 million, down 38% versus the prior year quarter, and excluded specified items of $49 million, primarily driven by restructuring charges.

 

1Q 2025 Segment Overview 

 

($ in millions, except where noted)

1Q 2025

1Q 2024

% Change

Total Segment Operating Profit1

$747

$1,196

(38)%

Segment Operating Profit:

 

 

 

Ag Services & Oilseeds

412

864

(52)%

Carbohydrate Solutions

240

248

(3)%

Nutrition

95

84

13%

 

 

 

 

_______________________________

1

Non-GAAP financial measures; see pages 6-7 and 13-16 for explanations and reconciliations.

2

All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis.

 
 

Ag Services and Oilseeds Summary

AS&O segment operating profit was $412 million during the first quarter of 2025, down 52% compared to the prior year quarter.

Ag Services subsegment operating profit was 31% lower versus the prior year quarter, driven by a decrease in volumes and margins, primarily due to tariff and trade policy uncertainty. Margins were also impacted by negative mark-to-market timing impacts during the quarter and the impact of certain export duties. These impacts were partially offset by higher destination marketing volumes and related margins in the quarter. There were approximately $30 million of net negative mark-to-market timing impacts during the quarter, compared to approximately $18 million of net positive impacts in the prior year quarter.

Crushing subsegment operating profit was 85% lower versus the prior year quarter, driven by lower margins due to increased industry capacity, competitive meal exports from Argentina, higher manufacturing costs, and lower vegetable oil demand due to biofuel and trade policy uncertainty. There were approximately $4 million of net positive mark-to-market timing impacts during the quarter, compared to approximately $40 million of net positive impacts in the prior year quarter.

The Refined Products and Other (RPO) subsegment operating profit was 21% lower versus the prior year quarter, as biofuel and trade policy uncertainty negatively impacted biodiesel margins. Softer oil demand and increased crush capacity also negatively impacted refining margins compared to the prior year quarter. There were approximately $4 million of net positive mark-to-market timing impacts during the quarter, compared to approximately $30 million of net negative impacts in the prior year quarter.

Equity earnings from the Company’s investment in Wilmar were approximately 52% lower versus the prior year quarter.

1Q 2025 AS&O Overview 

 

($ in millions, except where noted)

1Q 2025

1Q 2024

% Change

Segment Operating Profit

$412

$864

(52)%

Ag Services

159

232

(31)%

Crushing

47

313

(85)%

Refined Products and Other

134

170

(21)%

Wilmar

72

149

(52)%

 

 

 

 

Carbohydrate Solutions Summary

Carbohydrate Solutions segment operating profit was $240 million during the first quarter of 2025, down 3% compared to the prior year quarter.

The Starches & Sweeteners (S&S) subsegment operating profit decreased 21%, versus the prior year quarter, due to lower North America (NA) starch margins, lower EMEA S&S volumes and margins, and higher manufacturing costs. NA liquid sweetener margins and global wheat milling margins and volumes improved relative to the prior year quarter.

In the Vantage Corn Processor (VCP) subsegment, operating profit increased due to higher ethanol volumes and improved margins relative to the prior year quarter.

1Q 2025 Carbohydrate Solutions Overview 

 

($ in millions, except where noted)

1Q 2025

1Q 2024

% Change1

Segment Operating Profit

$240

$248

(3)%

Starches and Sweeteners

207

261

(21)%

Vantage Corn Processors

33

(13)

NM

 

 

 

 

1

NM: Not Meaningful. Percentage increases above 200% or when one period includes income and other period includes loss are considered not meaningful

 

Nutrition Summary

Nutrition segment operating profit was $95 million during the first quarter of 2025, a 13% increase compared to the prior year quarter, driven by Flavors, Animal Nutrition excluding Pet, and timing-related incentive compensation adjustments4.

Human Nutrition subsegment operating profit was $75 million, compared to $76 million in the prior year quarter. In Flavors, operating profit increased, primarily driven by higher volumes and margins in North America and EMEA. In Specialty Ingredients, operating profit declined, due to lower margins. In Health & Wellness, operating profit declined, due to certain negative valuation adjustments.

In the Animal Nutrition subsegment, operating profit was $20 million, up 150% relative to the prior year quarter, driven by improved market conditions, leading to higher margins, and cost optimization efforts.

1Q 2025 Nutrition Overview 

 

($ in millions, except where noted)

1Q 2025

1Q 2024

% Change

Segment Operating Profit

$95

$84

13%

Human Nutrition

75

76

(1)%

Animal Nutrition

20

8

150%

 

 

 

 

Corporate and Other Business Summary

For the first quarter, Other Business contributed operating profit of $96 million, down 21% compared to the prior year quarter due to lower ADM Investor Services results on lower interest income and customer deposit balances. Captive insurance results declined on lower interest income.

In Corporate for the first quarter, costs were higher versus the prior year quarter driven by timing-related incentive compensation adjustments4, partially offset by lower financing costs and the lapping of ADM Ventures investment valuation losses reflected in the prior year quarter.

Outlook3

Based on the current environment, the Company affirms its previously provided adjusted earnings per share1,2 in the range of $4.00 to $4.75 for the full year 2025, though it now expects to be at the lower end of the guidance range.

_______________________________

1

Non-GAAP financial measures; see pages 6-7 and 13-16 for explanations and reconciliations.

2

All references in this document to earnings per share (EPS) and adjusted earnings per share reflect EPS on a diluted basis.

3

Forecasted GAAP Earnings Reconciliation: ADM is not presenting forecasted GAAP earnings per diluted share or a quantitative reconciliation to forecasted adjusted earnings per share in reliance on the unreasonable efforts exemption provided under Item 10(e)(1)(i)(B) of Regulation S-K. ADM is unable to predict with reasonable certainty and without unreasonable effort the impact of any impairment and timing of restructuring-related and other charges, along with acquisition-related expenses and the outcome of certain regulatory, legal and tax matters, as well as other potential reconciling items. The financial impact of these items is uncertain and is dependent on various factors, including timing, and could be material to our Consolidated Statements of Earnings. 

4

For the first quarter ended March 31, 2025, segment operating profit for Ag Services and Oilseeds, Carbohydrate Solutions and Nutrition segments includes positive impact of timing-related adjustments for incentive compensation payouts of $45 million, $12 million and $20 million, respectively. The offsetting adjustment of $77 million was recorded in Corporate with no net impact to ADM Consolidated Financial Statements. 

 

Conference Call Information

ADM will host a webcast today, May 6, 2025,at 9 a.m. Central Time to discuss financial results and outlook. To listen to the webcast, go to www.adm.com/webcast. A replay of the webcast will also be available for an extended period of time at www.adm.com/webcast.

About ADM

ADM unlocks the power of nature to enrich the quality of life. We’re an essential global agricultural supply chain manager and processor, providing food security by connecting local needs with global capabilities. We’re a premier human and animal nutrition provider, offering one of the industry’s broadest portfolios of ingredients and solutions from nature. We’re a trailblazer in health and well-being, with an industry-leading range of products for consumers looking for new ways to live healthier lives. We’re a cutting-edge innovator, guiding the way to a future of new bio-based consumer and industrial solutions. And we’re leading in business-driven sustainability efforts that support a strong agricultural sector, resilient supply chains, and a vast and growing bioeconomy. Around the globe, our expertise and innovation are meeting critical needs from harvest to home. Learn more at www.adm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this release, are forward-looking statements. You can identify forward-looking statements by the fact they do not relate strictly to historical or current facts. These statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “outlook,” “will,” “should,” “can have,” “likely,” “forecasted”, and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. All forward-looking statements are subject to significant risks, uncertainties and changes in circumstances that could cause actual results and outcomes to differ materially from the forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties, including, without limitation, those described in the Company’s most recent Annual Report on Form 10-K and in other documents that the Company files or furnishes with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Except to the extent required by law, ADM does not undertake, and expressly disclaims, any duty or obligation to update publicly any forward-looking statement after the date of this announcement, whether as a result of new information, future events, changes in assumptions or otherwise.

Non-GAAP Financial Measures

The Company uses certain “Non-GAAP” financial measures as defined by the Securities and Exchange Commission. These are measures of performance not defined by accounting principles generally accepted in the United States (GAAP), and should be considered in addition to, not in lieu of, GAAP reported measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are included in this press release.

Adjusted net earnings and Adjusted earnings per share (EPS). Adjusted net earnings reflects ADM’s reported net earnings after removal of the effect on net earnings of specified items as more fully described in the reconciliation tables below. Adjusted EPS reflects ADM’s diluted EPS after removal of the effect on EPS as reported of specified items as more fully described in the reconciliation tables below. Management believes that Adjusted net earnings and Adjusted EPS are useful measures of ADM’s performance because they provide investors additional information about ADM’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. These non-GAAP financial measures are not intended to replace or be alternatives to net earnings and EPS as reported, the most directly comparable GAAP financial measures, or any other measures of operating results under GAAP. Earnings amounts described above have been divided by the company’s diluted shares outstanding for each respective period in order to arrive at an adjusted EPS amount for each specified item.

Total segment operating profit. Total segment operating profit is ADM’s consolidated earnings before income taxes adjusted for Other Business, Corporate, and specified items as more fully described in the reconciliation tables below. Management believes that total segment operating profit is a useful measure of ADM’s performance because it provides investors information about ADM’s reportable segment performance excluding Other Business, Corporate overhead costs as well as specified items. Total segment operating profit is not a measure of consolidated operating results under GAAP and should not be considered an alternative to earnings before income taxes, the most directly comparable GAAP financial measure, or any other measure of consolidated operating results under GAAP.

Adjusted Return on Invested Capital (ROIC). Adjusted ROIC is Adjusted ROIC earnings divided by adjusted invested capital. Adjusted ROIC earnings is ADM’s net earnings adjusted for the after-tax effects of interest expense on borrowings and specified items. Adjusted invested capital is the sum of ADM’s equity (excluding redeemable and non-redeemable non-controlling interests) and interest-bearing liabilities (which totals invested capital), adjusted for specified items. Management believes Adjusted ROIC is a useful financial measure because it provides investors information about ADM’s returns excluding the impacts of specified items and increases period-to-period comparability of underlying business performance. Management uses Adjusted ROIC to measure ADM’s performance by comparing Adjusted ROIC to its weighted average cost of capital (WACC). Adjusted ROIC, Adjusted ROIC earnings and Adjusted invested capital are non-GAAP financial measures and are not intended to replace or be alternatives to GAAP financial measures.

EBITDA is defined as earnings before interest on borrowings, taxes, depreciation and amortization. Adjusted EBITDA is defined as earnings before interest on borrowings, taxes, depreciation, and amortization, adjusted for specified items. The Company calculates adjusted EBITDA by removing the impact of specified items and adding back the amounts of income tax expense, interest expense on borrowings, and depreciation and amortization to net earnings. Management believes that EBITDA and adjusted EBITDA are useful measures of the Company’s performance because they provide investors additional information about the Company’s operations allowing better evaluation of underlying business performance and better period-to-period comparability. EBITDA and adjusted EBITDA are non-GAAP financial measures and are not intended to replace or be an alternative to net earnings, the most directly comparable GAAP financial measure.

Cash flows from operations before working capital is defined as cash flows from operating activities adjusted for changes in operating assets and liabilities as presented in the Company’s consolidated statement of cash flows. Management believes that cash flows from operations before working capital is a useful measure of the Company’s cash generation. Cash flows from operations before working capital is a non-GAAP financial measure and is not intended to replace or be an alternative to cash from operating activities, the most directly comparable GAAP financial measure.

Financial Tables Follow

Source: Corporate Release

Source: ADM

 
 
 

Segment Operating Profit and Corporate Results

(unaudited) 

 

 

Quarter ended

 

 

March 31,

 

(In millions)

 

2025

 

 

2024

 

Change

 

 

 

 

Segment Operating Profit

 

 

 

Ag Services and Oilseeds

$

412

 

$

864

 

$

(452

)

Ag Services

 

159

 

 

232

 

 

(73

)

Crushing

 

47

 

 

313

 

 

(266

)

Refined Products and Other

 

134

 

 

170

 

 

(36

)

Wilmar

 

72

 

 

149

 

 

(77

)

 

 

 

 

Carbohydrate Solutions

$

240

 

$

248

 

$

(8

)

Starches and Sweeteners

 

207

 

 

261

 

 

(54

)

Vantage Corn Processors

 

33

 

 

(13

)

 

46

 

 

 

 

 

Nutrition

$

95

 

$

84

 

$

11

 

Human Nutrition

 

75

 

 

76

 

 

(1

)

Animal Nutrition

 

20

 

 

8

 

 

12

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Results

$

(441

)

$

(426

)

$

(15

)

 

 

 

 

Interest expense – net

 

(100

)

 

(110

)

 

10

 

Unallocated corporate costs

 

(352

)

 

(304

)

 

(48

)

Other

 

16

 

 

 

 

16

 

Specified items:

 

 

 

Restructuring (charges) adjustment

 

(5

)

 

(12

)

 

7

 

 
 
 
 

Consolidated Statements of Earnings

(unaudited) 

 

 

Quarter ended

 

March 31,

 

 

2025

 

 

 

2024

 

 

(in millions, except per share amounts)

 

 

 

 

Revenues

$

20,175

 

 

$

21,847

 

Cost of products sold

 

18,995

 

 

 

20,188

 

Gross Profit

 

1,180

 

 

 

1,659

 

Selling, general, and administrative expenses

 

932

 

 

 

951

 

Asset impairment, exit, and restructuring costs

 

38

 

 

 

18

 

Equity in (earnings) of unconsolidated affiliates

 

(144

)

 

 

(212

)

Interest and investment income

 

(138

)

 

 

(123

)

Interest expense

 

158

 

 

 

166

 

Other (income) – net

 

(19

)

 

 

(26

)

Earnings Before Income Taxes

 

353

 

 

 

885

 

Income tax expense

 

61

 

 

 

166

 

Net Earnings Including Non-controlling Interests

 

292

 

 

 

719

 

 

 

 

 

Less: Net (losses) attributable to non-controlling interests

 

(3

)

 

 

(10

)

Net Earnings Attributable to ADM

$

295

 

 

$

729

 

 

 

 

 

Diluted earnings per common share

$

0.61

 

 

$

1.42

 

 

 

 

 

Average number of diluted shares outstanding

 

483

 

 

 

514

 

 
 
 
 

Summary of Financial Condition

(unaudited) 

 

 

 

March 31,

2025

 

March 31,

2024

 

 

(in millions)

Net Investment In

 

 

 

 

Cash and cash equivalents

 

$

864

 

$

830

Short-term marketable securities

 

 

33

 

 

Operating working capital

 

 

10,283

 

 

10,181

Property, plant, and equipment

 

 

11,000

 

 

10,596

Investments in affiliates

 

 

5,022

 

 

5,566

Goodwill and other intangibles

 

 

6,875

 

 

7,051

Other non-current assets

 

 

2,623

 

 

2,612

 

 

$

36,700

 

$

36,836

Financed By

 

 

 

 

Short-term debt

 

$

2,765

 

$

1,734

Long-term debt, including current maturities

 

 

8,300

 

 

8,246

Deferred liabilities

 

 

3,253

 

 

3,317

Temporary equity

 

 

255

 

 

307

Shareholders’ equity

 

 

22,127

 

 

23,232

 

 

$

36,700

 

$

36,836

 
 
 
 

Summary of Cash Flows

(unaudited) 

 

 

 

Three months ended

 

 

March 31

 

 

 

2025

 

 

 

2024

 

 

 

(in millions)

Cash flows from operating activities

 

 

 

 

Net earnings including non-controlling interests

 

$

292

 

 

$

719

 

Depreciation and amortization

 

 

287

 

 

 

280

 

Asset impairment charges

 

 

 

 

 

3

 

(Gain) Loss on sales / investment revaluation

 

 

(26

)

 

 

14

 

Other – net

 

 

(114

)

 

 

(134

)

Other changes in operating assets and liabilities

 

 

(781

)

 

 

(182

)

Net cash (used in) provided by operating activities (1)

 

 

(342

)

 

 

700

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

Capital expenditures

 

 

(291

)

 

 

(328

)

Net assets of businesses acquired

 

 

(90

)

 

 

(915

)

Proceeds from sales of assets

 

 

10

 

 

 

6

 

Purchases of marketable securities

 

 

(11

)

 

 

 

Proceeds from sales of marketable securities

 

 

248

 

 

 

 

Other – net

 

 

5

 

 

 

7

 

Net cash used in investing activities

 

 

(129

)

 

 

(1,230

)

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

Net borrowings under lines of credit agreements

 

 

863

 

 

 

1,619

 

Share repurchases, net of tax

 

 

 

 

 

(1,327

)

Cash dividends

 

 

(247

)

 

 

(257

)

Other – net

 

 

(29

)

 

 

(37

)

Net cash provided by (used in) financing activities

 

 

587

 

 

 

(2

)

Effect of exchange rate on cash, cash equivalents, restricted cash, and restricted cash equivalents

 

 

16

 

 

 

(13

)

Net increase (decrease) in cash, cash equivalents, restricted cash, and restricted cash equivalents

 

 

132

 

 

 

(545

)

Cash, cash equivalents, restricted cash, and restricted cash equivalents – beginning of year

 

 

3,924

 

 

 

5,390

 

Cash, cash equivalents, restricted cash, and restricted cash equivalents – end of year

 

$

4,056

 

 

$

4,845

 

1

Cash flows from operations before working capital is a Non-GAAP financial measure and is cash flows used in operating activities of $(342) million, adjusted for changes in working capital of $(781) million for the first quarter of 2025, and cash flows provided by operating activities of $700 million, adjusted for changes in working capital of $(182) million for the first quarter of 2024.

 
 
 
 

Segment Operating Analysis

(unaudited) 

 

 

Quarter ended

 

March 31,

 

2025

 

2024

 

(in ‘000s metric tons)

Certain processed volumes (by commodity)

 

 

 

Oilseeds

 

9,091

 

 

9,387

Corn

 

4,581

 

 

4,407

 

 

 

 

 

 

 

 

 

Quarter ended

 

March 31,

 

 

2025

 

 

2024

 

(in millions)

Revenues

 

 

 

Ag Services and Oilseeds

$

15,675

 

$

17,219

Carbohydrate Solutions

 

2,571

 

 

2,683

Nutrition

 

1,817

 

 

1,836

Total Segment Revenues

 

20,063

 

 

21,738

Other Business

 

112

 

 

109

Total Revenues

$

20,175

 

$

21,847

 
 
 
 

Total Segment Operating Profit

A Non-GAAP financial measure

(unaudited) 

 

 

Quarter ended

 

 

March 31,

 

(In millions)

 

2025

 

 

2024

 

Change

 

 

 

 

Earnings before income taxes

$

353

 

$

885

 

$

(532

)

Other Business (earnings)

 

(96

)

 

(121

)

 

25

 

Corporate

 

441

 

 

426

 

 

15

 

Specified items:

 

 

 

Impairment, exit, restructuring charges, and settlement contingencies

 

49

 

 

6

 

 

43

 

Total Segment Operating Profit

$

747

 

$

1,196

 

$

(449

)

 
 
 
 

Adjusted Net Earnings and Adjusted Earnings Per Share

Non-GAAP financial measures

(unaudited) 

 

 

Quarter ended March 31,

 

2025

2024

 

In millions

Per share

In millions

Per share

Net earnings and reported EPS (diluted)

$

295

$

0.61

$

729

$

1.42

Adjustments:

 

 

 

 

Impairment, exit, restructuring charges, and settlement contingencies (a)

 

43

 

0.09

 

18

 

0.03

Certain discrete tax adjustment (b)

 

 

 

3

 

0.01

Total adjustments

 

43

 

0.09

 

21

 

0.04

Adjusted net earnings and adjusted diluted EPS

$

338

$

0.70

$

750

$

1.46

(a)

Current quarter charges of $54 million pretax ($43 million after tax) were related to restructuring and contingencies, tax effected using the applicable tax rates. Prior-year quarter charges of $18 million pretax ($18 million after tax) were related to the impairment of certain assets and restructuring, tax effected using the applicable tax rates.

(b)

Tax expense adjustment due to certain discrete items totaling $3 million in the prior-year quarter.

 
 
 

Return on Invested Capital and Adjusted Return on Invested Capital

Non-GAAP financial measures

(unaudited) 

 

Adjusted ROIC Earnings (in millions)

 

 

 

 

 

 

 

 

Four Quarters

 

Quarter Ended

 

Ended

 

Jun. 30, 2024

 

Sep. 30, 2024

 

Dec. 31, 2024

 

Mar. 31, 2025

 

Mar. 31, 2025

 

 

 

 

 

 

 

 

 

 

Net earnings attributable to ADM

$

486

 

 

$

18

 

 

$

567

 

 

$

295

 

 

$

1,366

 

Adjustments:

 

 

 

 

 

 

 

 

 

Interest expense(3)

 

135

 

 

 

124

 

 

 

132

 

 

 

116

 

 

 

507

 

Tax on interest

 

(32

)

 

 

(30

)

 

 

(36

)

 

 

(28

)

 

 

(126

)

Total ROIC Earnings

 

589

 

 

 

112

 

 

 

663

 

 

 

383

 

 

 

1,747

 

Other adjustments, net of tax

 

22

 

 

 

512

 

 

 

(22

)

 

 

43

 

 

 

555

 

Total Adjusted ROIC Earnings

$

611

 

 

$

624

 

 

$

641

 

 

$

426

 

 

$

2,302

 

 

Adjusted Invested Capital (in millions)

 

 

 

 

 

 

 

 

 

 

Quarter Ended

 

Trailing Four

 

Jun. 30, 2024

 

Sep. 30, 2024

 

Dec. 31, 2024

 

Mar. 31, 2025

 

Quarter Average

 

 

 

 

 

 

 

 

 

 

Equity (1)

$

22,148

 

$

21,974

 

$

22,168

 

 

$

22,119

 

$

22,102

 

Interest-bearing liabilities(2)

 

10,576

 

 

10,051

 

 

10,180

 

 

 

11,088

 

 

10,474

 

Total Invested Capital

 

32,724

 

 

32,025

 

 

32,348

 

 

 

33,207

 

 

32,576

 

Other adjustments, net of tax

 

22

 

 

512

 

 

(22

)

 

 

43

 

 

139

 

Total Adjusted Invested Capital

$

32,746

 

$

32,537

 

$

32,326

 

 

$

33,250

 

$

32,715

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Return on Invested Capital

 

 

 

 

 

 

 

 

5.4

%

Adjusted Return on Invested Capital

 

 

 

 

 

 

 

 

7.0

%

(1)

Excludes non-controlling interests

(2)

Includes short-term debt, long term debt and finance lease obligations

(3)

Represents interest expense on borrowings and therefore excludes ADM Investor Services related interest expense 

 
 
 
 

Earnings Before Interest, Taxes, and Depreciation and Amortization (EBITDA) and Adjusted EBITDA

Non-GAAP financial measures

(unaudited) 

 

 

 

 

 

 

 

 

 

 

Four

Quarters

 

Four

Quarters

 

Quarter Ended

 

Ended

 

Ended

 

Jun. 30,

2024

 

Sep. 30,

2024

 

Dec. 31,

2024

 

Mar. 31,

2025

 

Mar. 31,

2025

 

Mar. 31,

2024

 

 

 

 

 

(in millions)

 

 

 

 

 

 

Net earnings

$

486

 

 

$

18

 

 

$

567

 

 

$

295

 

 

$

1,366

 

 

$

3,042

 

Net (losses) attributable to non-controlling interests

 

(5

)

 

 

 

 

 

(6

)

 

 

(3

)

 

 

(14

)

 

 

(29

)

Income tax expense

 

115

 

 

 

90

 

 

 

106

 

 

 

61

 

 

 

372

 

 

 

769

 

Interest expense(1)

 

135

 

 

 

124

 

 

 

132

 

 

 

116

 

 

 

507

 

 

 

445

 

Depreciation and amortization(2)

 

286

 

 

 

288

 

 

 

287

 

 

 

284

 

 

 

1,145

 

 

 

1,080

 

EBITDA

 

1,017

 

 

 

520

 

 

 

1,086

 

 

 

753

 

 

 

3,376

 

 

 

5,307

 

(Gain) loss on sales of assets and businesses

 

 

 

 

(1

)

 

 

(10

)

 

 

 

 

 

(11

)

 

 

(16

)

Impairment, exit, restructuring charges, and settlement contingencies

 

7

 

 

 

504

 

 

 

(16

)

 

 

54

 

 

 

549

 

 

 

378

 

Railroad maintenance expense

 

4

 

 

 

28

 

 

 

32

 

 

 

 

 

 

64

 

 

 

67

 

Expenses related to acquisitions

 

4

 

 

 

 

 

 

3

 

 

 

 

 

 

7

 

 

 

7

 

Adjusted EBITDA

$

1,032

 

 

$

1,051

 

 

$

1,095

 

 

$

807

 

 

$

3,985

 

 

$

5,743

 

(1)

Represents interest expense on borrowings and therefore excludes ADM Investor Services related interest expense

(2)

Excludes $3 million of accelerated depreciation recorded within restructuring changes as a specified item for the three months ended March 31, 2025.

 
 

 

Media Contact

Brett Lutz

[email protected]

312-634-8484

Investor Relations

Megan Britt

[email protected]

872-257-8378

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Environment Chemicals/Plastics Environmental Health Manufacturing Sustainability Food/Beverage Retail Agriculture Natural Resources

MEDIA:

Logo
Logo

Lantronix to Participate in the 22nd Annual Craig-Hallum Institutional Investor Conference on May 28, 2025

IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced that Lantronix CEO Saleel Awsare and CFO Brent Stringham will participate in one-on-one meetings with investors at the 22nd Annual Craig-Hallum Institutional Investor Conference to be held on May 28, 2025, at the Depot Renaissance Hotel in Minneapolis.

Interested investors should contact Lantronix CFO Brent Stringham at [email protected] to inquire about availability for a one-on-one meeting.

About Lantronix

Lantronix Inc. is a global leader of compute and connectivity IoT solutions that target high-growth markets, including Smart Cities, Enterprise and Transportation. Lantronix’s products and services empower companies to succeed in the growing IoT markets by delivering customizable solutions that enable AI Edge Intelligence. Lantronix’s advanced solutions include Intelligent Substations infrastructure, Infotainment systems and Video Surveillance, supplemented with advanced Out-of-Band Management (OOB) for Cloud and Edge Computing.

For more information, visit the Lantronix website.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking statements within the meaning of federal securities laws, including, without limitation, statements related to Lantronix products or leadership team. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition, or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; our ability to mitigate any disruption in our and our suppliers’ and vendors’ supply chains due to the COVID-19 pandemic or other outbreaks, wars and recent tensions in Europe, Asia and the Middle East, or other factors; future responses to and effects of public health crises; cybersecurity risks; changes in applicable U.S. and foreign government laws, regulations, and tariffs; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; the level of our indebtedness, our ability to service our indebtedness and the restrictions in our debt agreements; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission (the “SEC”) on Sept. 9, 2024, including in the section entitled “Risk Factors” in Item 1A of Part I of that report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. In addition, actual results may differ as a result of additional risks and uncertainties about which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of the Nasdaq Stock Market LLC. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.

Lantronix Media Contact:        
Gail Kathryn Miller
Corporate Marketing &
Communications Manager
[email protected]

Lantronix Analyst and Investor Contact:        
[email protected]

©2025 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.



Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

HOUSTON–(BUSINESS WIRE)–
Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that an abstract will be presented at the American Thoracic Society 2025 Annual Conference, which is being held May 16-21 in San Francisco.

The abstract highlights the role of STAT3 as a master regulator of idiopathic pulmonary fibrosis (IPF). In preclinical studies, TTI-101, Tvardi’s STAT3 inhibitor, suppressed fibrotic markers which are not addressed with currently approved therapies (nintedanib and pirfenidone).

Using single-cell RNA sequencing on lung samples from untreated IPF patients and those treated with current approved therapies, McKenna et al. mapped the transcriptional landscape across 40 pulmonary cell types. They found ~60% of IPF-associated dysregulated genes are not addressed by either approved drug, which they termed the “IPF therapeutic gap.” They further identified STAT3 as a dominant regulatory transcription factor both in untreated IPF samples and in the “IPF therapeutic gap.”

In addition, ex vivo analysis of human lung slices treated with TTI-101, nintedanib or pirfenidone resulted in greater repression of genes within alveolar fibroblast (key effector cells in fibrosis) with TTI-101 vs current approved therapies. Notably, TTI-101 downregulated genes involved in extracellular matrix production, including collagen genes, which were largely unaffected by nintedanib or pirfenidone.

Details of the presentation are as follows:

 

Title:

Single Cell Transcriptomics in A Treatment Status Segregated Cohort Exposes a STAT-3-Regulated Therapeutic Gap in Idiopathic Pulmonary Fibrosis

 

Abstract #

11766

 

Session:

C18 – Spatial and Single-Cell Analysis of Lung Disease: Bridging Early Mechanisms to Therapeutic Gaps

 

Date/time:

Tuesday, May 20, 2025, 10:03am-10:15am PT (1:03pm-1:15pm ET)

Tvardi team members will also be hosting a booth:

 

Booth:

CT-11

 

Date/time:

Sunday, May 18, 2025, through Tuesday, May 20, 2025, 10:30 am-3:30 pm PT

For additional information, or to register for the conference: https://ats2025.d365.events/

About Tvardi Therapeutics

Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting Phase 2 clinical trials in fibrosis-driven diseases with high unmet need: idiopathic pulmonary fibrosis (NCT05671835) and hepatocellular carcinoma (NCT05440708). To learn more, please visit tvarditherapeutics.com or follow us on LinkedIn and X (Twitter).

Cautionary Statement Regarding Forward-looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Examples of these forward-looking statements include statements concerning the anticipated benefits of Tvardi’s product candidates; its ongoing clinical trials; and other statements regarding management’s intentions, plans, beliefs, expectations or forecasts for the future, and, therefore, you are cautioned not to place undue reliance on them.

Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are subject to a number of risks, including, among other things: the uncertainties associated with Tvardi’s product candidates, as well as risks associated with the clinical development and regulatory approval of product candidates, including potential delays in the completion of clinical trials; the significant net losses Tvardi has incurred since inception; Tvardi’s ability to initiate and complete ongoing and planned preclinical studies and clinical trials and advance its product candidates through clinical development; the timing of the availability of data from Tvardi’s clinical trials; the outcome of preclinical testing and clinical trials of the Tvardi’s product candidates, including the ability of those trials to satisfy relevant governmental or regulatory requirements; Tvardi’s plans to research, develop and commercialize its current and future product candidates; the clinical utility, potential benefits and market acceptance of Tvardi’s product candidates; the requirement for additional capital to continue to advance these product candidates, which may not be available on favorable terms or at all; Tvardi’s ability to attract, hire, and retain skilled executive officers and employees; Tvardi’s ability to protect its intellectual property and proprietary technologies; Tvardi’s reliance on third parties, contract manufacturers, and contract research organizations; the possibility that Tvardi may be adversely affected by other economic, business, or competitive factors; risks associated with changes in applicable laws or regulations; those factors discussed in Tvardi’s filings with the Securities and Exchange Commission, including the “Risk Factors” section of the Registration Statement on Form S-4, as amended (File No. 333-283900) initially filed with the Securities and Exchange Commission (the “SEC”) on December 18, 2024 and declared effective by the SEC on February 14, 2025, and Tvardi’s other documents subsequently filed with or furnished to the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. The combined company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

For Tvardi:

Tvardi Investor Relations

[email protected]

PJ Kelleher

LifeSci Advisors

617-430-7579

[email protected]

KEYWORDS: United States North America California Texas

INDUSTRY KEYWORDS: Oncology Health Clinical Trials Research Science Pharmaceutical Biotechnology

MEDIA: